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ABSTRACT 
Attention Deficit-Hyperactivity Disorder and 
Undifferentiated-Attention Deficit Disorder: 
Differences in Cognitive and Affective 
Characteristics and Responses to 
Stimulant Medication 
by 
Richard Alan Campbell, Doctor of Philosophy 
Utah State University, 1991 
Major Professor: Sebastian Striefel, Ph . D. 
Department: Psychology 
ix 
The cognitive and affective characteristics and 
responses to stimulant medication of children who were 
diagnosed as having attention deficit-hyperactivity 
disorder (AD-HD) or undifferentiated-attention deficit 
disorder (UADD) were investigated using a pretest-posttest 
experimental design. Nineteen AD-HD and 17 UADD children 
were compared using unpaired t-tests, prior to initiation 
of stimulant medication,on measures of intellectual 
functioning, impulsivity, problem behavior, and 
self-reported depression and self-esteem. Children from 
both the AD-HD (n = 12) and UADD (n = 12) groups were then 
compared before and after a 3-month trial of stimulant 
medication on measures of impulsivity, problem behavior, 
and self-reported depression and self-esteem using repeated 
measures analyses of variance. 
x 
No significant differences were found between 
groups in cognitive ability, impulsivity, depression, 
self-esteem, anxiety, peer relationships, or social 
withdrawal. AD-HD children were found to exhibit more 
hyperactive, aggressive, and delinquent problem behavior. 
Significant improvement was found in both groups in 
self-reported depression and self-esteem following a trial 
of stimulant medication. A trial of stimulant medication 
was found to reduce hyperactive problem behavior in AD-HD 
children. Stimulant medication had a beneficial effect on 
peer relationships and aggressive problem behavior in UADD 
children but did not produce similar positive effects in 
AD-HD children. These results are discussed as in 
relationship to the issue of whether AD-HD and UADD are 
separate syndromes and to the previous literature regarding 
attention deficit disorder with hyperactivity (ADD/H) and 
attention deficit disorder without hyperactivity (ADD/WO). 
Ramifications regarding appropriate treatment are also 
discussed. 
(149 pages) 
Introduction 
CHAPTER I 
STATEMENT OF THE PROBLEM 
Attention-deficit hyperactivity disorder (AD-HD) is a 
heterogeneous childhood disorder of unknown etiology. It 
is one of the most common behavior disorders of childhood 
(Cantwell, 1982) and one of the most frequent reasons for 
referral to child guidance clinics (Lahey, Delamater, & 
Kupfer, 1980). According to the American Psychiatric 
Association's (1987) Diagnostic and Statistical Manual of 
Mental Disorders-Third Edition-Revised (DSM-III-R), the 
essential features of the disorder are inattention, 
impulsivity, and hyperactivity exhibited to varying degrees 
by individuals and with onset of symptoms in late infancy 
or early childhood. The incidence of AD-HD is estimated to 
be approximately 3% of the school-age population and is 6-9 
times more prevalent in males than in females. Follow-up 
studies indicate that AD-HD is a pervasive disorder of 
which children continue to display symptoms in adolescence 
and adulthood (Klee, Garfinkel, & Beauchesne, 1986; Wender, 
Reimher, & Wood, 1981). Affected children are at 
risk of developing conduct disorders in adolescence and 
severe psychopathology in adulthood (Weiss & Hechtman, 
1986). Psychostimulants have been widely used in the 
treatment of AD-HD, with demonstrated effectiveness 
(Kavale, 1982; Rapaport, 1983). 
AD-HD is one of the most widely researched childhood 
psychiatric disorders (Varley, 1984). Yet, despite the 
considerable research that has been generated on AD-HD, 
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there remain confusion and controversy concerning the 
disorder. This is reflected in the recurrent relabeling of 
the disorder. The current DSM-III-R diagnostic category of 
AD-HD was originally labeled hyperkinetic reaction of 
childhood in the DSM-II (American Psychiatric Association, 
1968). It was revised to the category of attention-deficit 
disorder (ADD) in the Diagnostic and Statistical Manual of 
Mental Disorders-Third Edition (DSM-III; American 
Psychiatric Association, 1980). The essential features of 
ADD, according to the DSM-III, were developmentally 
inappropriate inattention and impulsivity of at least 
six-months duration and with onset of symptoms prior to age 
seven. The DSM-III category of ADD emphasized the 
problems of inattention and impulsivity as the core 
problematic symptoms. It provided for two subtypes, 
attention-deficit disorder with hyperactivity (ADD/H) and 
attention-deficit disorder without hyperactivity (ADD/WO). 
However, it has not been clear whether the 
subcategorization of ADD subtypes into ADD/Hand ADD/WO is 
valid or clinically useful (Barkely, 1987). 
Little research has been conducted regarding the 
distinction between ADD/Hand ADD/WO subtypes. Most 
research since the publication of the DSM-III has ignored 
the subcategorization of ADD by referring to the disorder 
as ADD without specifying ADD/Hor ADD/WO subtypes (Lahey, 
Schaughency, Strauss, & Frame, 1984). In a review of the 
limited number of published studies comparing ADD/Hand 
ADD/WO subtypes, Carlson (1986) concluded that the two 
subtypes display quite different behavior patterns. 
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According to Carlson, children with ADD/WO typically 
display poor academic functioning, unpopularity with peers, 
lack of motivation, drowsiness, shyness, and social 
withdrawal and typically do not exhibit conduct problems. 
Children with ADD/H, similarly to children with ADD/WO, 
also typically display poor academic functioning but are 
often more socially rejected by peers and exhibit more 
aggression and conduct disorders. 
Several studies have demonstrated an overlap of ADD 
and conduct disorders without distinguishing between ADD 
subtypes (Shapiro & Garfinkel, 1986; Steinhausen & Gobel, 
1985; Stewart, Cummings, Singer, & de Blois, 1981; Trites & 
Laprade, 1983). Others have demonstrated an overlap of ADD 
and affective disorders (Biederman, Munir, Armantano, 
Autor, Waternaux, & Tsuang, 1987; Bohline, 1985). Only a 
few of the studies that have focused on defining 
characteristics of ADD/Hand ADD/WO groups, however, have 
investigated the presence of anxiety or depression 
symptoms. Lahey et al. (1984) and Neeper (1985) reported 
on the basis of teacher ratings that their samples of 
children with ADD/WO were perceived by teachers as being 
more anxious than controls. On the other hand, Edelbrock, 
Costello, and Kessler (1984) found that ADD/Hand ADD/WO 
groups did not differ from each other or controls, as 
measured by teacher ratings of anxiety. Lahey et al. 
(1984) also reported subjects in both groups as being more 
depressed than controls, as determined by the subjects' 
ratings of themselves on a self-report measure of 
depression. This is the only study published to date 
investigating depression in children with ADD/WO. 
Carlson (1986) identified several limitations with 
the existing research on ADD/WO. One limitation was the 
overall low number of children with ADD/WO in the 
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various studies. Another limitation was related to the 
populations from which the samples were obtained. Of the 
10 studies on ADD/WO, only two used clinical populations 
where subjects were drawn from children referred to child 
guidance clinics for identified problem behavior. Of the 
two studies using clinical populations, both diagnosed 
children on the basis of retrospective analysis of existing 
clinical records. The remaining studies experimentally 
identified subjects using teacher ratings of children from 
regular and special education classrooms. Prospective 
studies consisting of subjects from clinical populations 
identified by comprehensive evaluations and with adequate 
sample sizes of children diagnosed as having ADD/WO would 
have provided useful information concerning the clinical 
utility of the subcategorization and would have allowed 
stronger conclusions to be drawn concerning ADD/WO. Given 
the present state of knowledge concerning the subtypes of 
ADD/Hand ADD/WO, it has not been clear whether the ADD/H 
and ADD/WO groups are subtypes of a single disorder or 
whether they are two distinct disorders. 
Further research in this area would have been 
desirable. However, because of a lack of empirical 
evidence substantiating the subcategorizing of the ADD 
category, it was revised in the latest publication of the 
DSM, (Barkley, 1987) thus rendering the diagnostic 
nomenclature of the DSM-III no longer current. Future 
research would be more clinically meaningful using the 
DSM-III-R criteria. 
The DSM-III-R (American Psychiatric Association, 1987) 
considers the ADD/Hand ADD/WO subtypes as two distinct 
' 
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disorders, attention-deficit hyperactivity Disorder (AD-HD) 
and undifferentiated attention-deficit disorder (UADD), 
respectively. The diagnostic category of AD-HD considers 
hyperactivity as a primary symptom of the disorder, along 
with inattention and impulsivity, and appears similar to 
the subtype of ADD/H. The DSM-III-R considers the 
essential feature of UADD to be developmentally 
inappropriate inattention and suggests "that some of the 
disturbances that in the DSM-III would have been 
categorized as ADD/WO could be included in this category." 
The DSM-III-R specified that future research is needed to 
determine the validity of this category and its 
differentiation from AD-HD. 
Because of the recency of the DSM-III-R's 
publication, there is a lack of research on the distinction 
between AD-HD and UADD. It is not clear whether they are 
two distinct disorders or subtypes of the same disorder. 
Further, it is not clear whether there are differences in 
the clinical characteristics of the two disorders and, if 
so, whether such differences would suggest possible 
differences between AD-HD and UADD in terms of prognosis 
and treatment. For example, Carlson (1986) has pointed out 
that the presence of aggression and conduct problems has 
been highly correlated with poor teenage outcomes for 
children identified as hyperactive (Loney, Kramer, & 
Milich, 1983). In addition, it is not known whether 
treatment interventions (e.g., stimulant medication) which 
have been demonstrated to be effective with children with 
AD-HD (or ADD/H) are as effective with children with UADD 
(or ADD/WO). No research has been published to date in 
this area. It may be that the treatment needs of children 
with UADD are quite different from children with AD-HD. 
Research efforts focusing on the distinction between the 
DSM-III-R categories of AD-HD and UADD in terms of their 
characteristics and treatment would contribute clinically 
useful information to the knowledge base of the field. 
Statement of the Problem 
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There is a lack of research regarding the distinction 
between the DSM-III-R categories of AD-HD and UADD. 
Research is needed clarifying the differences in the 
cognitive, behavioral, and affective characteristics of 
children with AD-HD and DADD. Research is also needed to 
determine appropriate treatment interventions for DADD. 
Research investigating both the clinical characteristics of 
the disorders AD-HD and DADD and their treatment is needed 
to better define the clinical population with these two 
disorders and the validity of the two classifications. 
Purpose and Objectives 
The intent of the present study was to examine 
the characteristics and treatment of children with AD-HD 
and UADD in order to better clarify the clinical pictures 
of the two disorders and their treatment. 
Specifically, the objectives of the study were the 
following: 
1. To identify the differences, if any, between 
children diagnosed as AD-HD and UADD on measures of 
intelligence, attention and impulsivity, behavior, 
depression, and self-esteem. The hypothesis tested was 
that there will be no significant difference (2 < .05) 
between children with AD-HD and children with UADD 
on intelligence scores, impulsivity, parent and teacher 
ratings of problem behavior, self-reported depression, or 
self-esteem. 
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2. To determine the effectiveness of stimulant 
medication for children with UADD and AD-HD on measures of 
intelligence, impulsivity, behavior, depression, and 
self-esteem, and to determine the differences, if any, 
between the two groups. The hypotheses were as follows: 
(a) There will be no significant differences (2 < .05) 
between pretest and posttest measures of impulsivity, 
parent and teacher ratings of problem behavior, and 
self-reported depression and self-esteem for children with 
UADD or AD-HD who received stimulant medication as 
treatment and (b) there will be no significant differences 
(2 < .05) between children with AD-HD or UADD who have 
received stimulant medication as treatment on measures of 
impulsivity, parent and teacher ratings of problem 
behavior, or self-reported depression or self-esteem before 
or after treatment. 
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CHAPTER II 
REVIEW OF THE LITERATURE 
Attention 
Attention is a complex neuropsychological construct 
which has enjoyed considerable investigation, particularly 
in regard to the study of children with attention-deficit 
disorders. Skinner (1953, 1969) conceptualized attention 
as a relationship or correlation between a stimulus and a 
response. Attention, in a behavioral framework, refers to 
the probability that a particular behavior will occur in 
the presence of a given stimulus. Skinner described this 
as stimulus control. Given such a perspective, variables 
that account for the poor correlation between a particular 
stimulus (e.g., a task) and the response (e.g., a child's 
behavior) are more important than implying a particular 
attention deficit (Barkley, 1988). If a child fails to 
respond to a task, then it is suggested that the task fails 
to provide enough stimulus control over the child's 
behavior. Stimulus control is dependent upon a number of 
factors including the maturation and/or the development of 
the child's nervous system and the physical properties of 
the stimulus. Another factor is the learning history of 
the child. The likelihood of a behavior occuring in the 
future when in the presence of the stimulus is dependent 
upon the contingency history (i.e., reinforcing or 
punishing events in the past that occured in the presence 
of a particular stimulus) of the child. Barkley (1988) 
suggests that sustained attention is said to be developing 
when the child attends longer and ionger after being 
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reinforced for responding in the presence a stimulus. 
Impulse control is said to be developing when a child 
inhibits certain responses after being punished for a 
response in the presence of a particular stimulus. In such 
a framework, certain attention deficits to certain tasks 
may be a result of inadequate reinforcement histories. 
Other attentional problems may be the result of inadequate 
neurological substrates within the individual (Barkley, 
1988) . 
Barkley (1988), in a review of attention processes, 
conceptualized attention as a multidimensional construct 
with several components. The components include (a) 
alertness or arousal, which refers to the degree of general 
wakefulness or state of responsiveness of the child to the 
environment; (b) selective or focused attention, which 
means the child's ability to focus on specific stimuli 
essential to a task in the presence of distracting 
elements; (c) distractibility, which relates to the degree 
to which a child responds to unessential aspects of a task; 
(d) impulsivity, which refers to the speed with which a 
child reacts to a stimulus, and has received considerable 
investigation in regards to ADD children (Douglas & Peters, 
1979; Milich & Kramer, 1984); (e) sustained 
attention/vigilance, which refers to the time spent 
persisting to a task; (f) span of apprehension, which 
refers to the number of stimuli to which the child can 
attend simultaneously; and finally, (g) search, which 
refers to the strategies or rules the child uses while 
performing a task. 
It has been suggested that 49% of boys and 27% of 
girls are described by teachers as inattentive (Lapouse & 
Monk, 1958; Werry & Quay, 1971). Serious attention 
deficits are estimated to occur in at least 3 to 10% of 
school-age children, making them the most prevalent of all 
childhood neuropsychological disorders (Barkley, 1981; 
Ross & Ross, 1982). Additionally, attentional deficits 
are commonly associated with other childhood disorders 
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such as autism, pervasive developmental disorders, 
depression, conduct disorders, learning disabilities, 
closed-head injury, epilepsy, tic disorders, and other 
neurological conditions. Cognitively, attention deficits 
lead to difficulties in short-term memory, problem-solving, 
motor planning, coordination, and execution of tasks 
(Douglas, 1983). Further, attention deficits may have 
negative effects on the child's social interactions with 
parents, peers, and teachers (Barkley, 1985). Overall, 
attention deficits can have wide ranging negative effects 
on the child's cognitive, academic, and social functioning. 
As a result, child psychologists and neuropsychologists are 
very likely to be working a great deal with attentional 
deficits in children. 
Hyperactivity, or attention deficit-hyperactivity 
disorder (AD-HD), as described by the American Psychiatric 
Association's (1987) Diagnostic and Statistical Manual of 
Mental Disorders-Third Edition-Revised (DSM-III-R), is one 
of the most common behavior disorders of childhood 
(Barkley, 1981; Cantwell, 1982; Ross & Ross, 1982) and one 
of the most frequent reasons for referral to child 
guidance clinics (Lahey et al., 1980; Trites, Dugas, & 
Lynch, 1979). Due in large part to the interest, 
confusion, and controversy regarding the disorder, AD-HD 
has been the most widely studied childhood disorder during 
the last three decades. Well over 2700 research articles 
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and numerous books have been published in the field (Weiss 
& Hechtman, 1986). 
Despite the extensive research that has been 
generated, confusion still exists concerning the 
definition, diagnosis, etiology, prognosis, and treatment 
of AD-HD. Ross and Ross stated in their text, 
Hyperactivity is unique among the childhood 
disorders in that the whole field is characterized 
to an unusual degree by uncertainty, contradictions, 
the unexpected, and the bizzare. (1982, p. 6) 
Indeed, despite the voluminous research that has been 
published, many questions regarding AD-HD remain 
unanswered. One is referred to texts by Conners and Wells 
(1986), Weiss and Hechtman (1986), Ross and Ross (1982), 
and Barkley (1981) for thorough discussions of the 
literature. In this review, an overview of the 
definition, diagnosis, etiology, prognosis, and treatment 
of AD-HD is provided as it relates to a general 
understanding of the disorder and as it pertains to the 
rationale and design of the present study. 
History and Definition 
In the published literature, AD-HD has been referred 
to by a variety of labels over the years, including 
attention deficit disorder with or without hyperactivity, 
hyperactivity, hyperkinesis, hyperkinetic impulse disorder, 
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minimal brain dysfunction, and minimal brain disorder. The 
many diagnostic labels reflect the progression and 
divergence in thinking between various researchers and 
theorists concerning the definition, diagnosis, and 
etiology of AD-HD. 
Reports about hyperactive children can be found as 
early as the mid-1800's. In 1854, Hoffman, a German 
physician, described a youngster he named Fidgety Phil, who 
exemplified a group of children who displayed many 
behavioral characteristics of hyperactivity. The 
earliest paper published in the literature (Still, 1902) 
described a cluster of behaviors including restlessness, 
impulsivity, poor concentration, and overactivity in groups 
of retarded or brain damaged children. Still (1902) 
ascribed these behaviors to "defects in moral control" and 
believed organic factors to be chiefly responsible for 
their existence. Bradley (1937) demonstrated that 
stimulant medication could amelioarate hyperactive behavior 
in some hyperactive children. Strauss and Kephart (1955), 
based on Bradley's "paradoxical quieting effect'', concluded 
that those children exhibiting similar behaviors described 
by Still must be "minimally brain damaged". It has since 
been argued that the brain damage etiology hypothesis is 
inappropriate since less than 5% of children with 
neurological impairment exhibit hyperactive behaviors 
(Cantwell, 1982; Routh, 1978). However, more recent 
research has suggested that there are some brain anamolies 
in children with AD-HD and will be reviewed in a later 
section. 
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Laufer and Denhoff (1957) provided the first 
systematic description of the hyperkinetic impulse 
syndrome, associating hyperactivity, short attention span, 
poor concentration, variability in performance and 
behavior, impulsiveness and inability to delay 
gratification, irritability, explosiveness, and poor school 
work to the syndrome. Laufer and Denhoff proposed 
hyperkinesis to be a medical syndrome resulting from a 
defect in the functioning of the diencephalon in the brain 
and recommended a multi-faceted treatment approach 
including stimulant medication, education, and 
psychotherapy. 
The Diagnostic and Statistical Manual of Mental 
Disorders-Second Edition (DSM-II; APA, 1968) provided a 
diagnostic category of Hyperkinetic Reaction of Childhood, 
which reflected the Laufer-Denhoff syndrome's description . 
Excessive motor activity was proposed to be the 
primary problematic symptom of the disorder and research 
efforts were directed at objectively measuring motor 
activity. 
Research during the 1970's suggested that the 
hyperactive child's symptomotalogy was more widespread than 
simply the presence of excessive motor activity. 
Noncompliance to parental commands, excessive 
attention-seeking, increased need for adult supervision, 
decreased positive interactions between children and 
mothers (Barkley & Cunningham, 1979; Campbell, 1975) and, 
most importantly, attention deficits (Douglas, 1972) 
received considerable research attention. These findings 
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were taken into account when the DSM-II was revised. The 
Diagnostic and Statistical Manual of Mental Disorders-Third 
Edition (DSM-III; APA, 1980) relabeled the DSM-II 
category of hyperkinetic reaction to attention-deficit 
disorder (ADD). Inattention and impulsivity were 
identified as the primary characteristics of the 
disorder. Further, the disorder could be diagnosed in two 
ways, as involving hyperactivity (ADD/H) or not involving 
hyperactive behavior (ADD/WO). This reflected a major 
shift in thinking about the disorder; the assumption that 
there are two subtypes of this disorder, and also that 
excess motor activity was not a sole symptom. 
The revised edition of the DSM-III, published in 1987, 
eliminated the subcategorization of ADD. Instead, the 
category of attention deficit-hyperactivity disorder 
(AD-HD) was established, the primary symptoms of which are 
inattention, impulsivity and excessive motor activity. A 
second category, undifferentiated-attention deficit 
disorder (UADD), was included in the DSM-III-R, the 
primary symptom of which is inattention . Individuals 
receiving this diagnosis display symptomatology similar to 
those previously diagnosed in the DSM-III as ADD/WO. 
Further empirical investigations are needed to determine 
the validity of this category (American Psychiatric 
Association, 1987). 
Since publication of the DSM-III and prior to the 
publication of the DSM-III-R, limited research has been 
generated on the subcategorization of ADD into ADD/Hand 
ADD/WO. Carlson, Lahey, and Neeper (1987) attempted to 
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determine differences in the cognitive correlates of ADD/H 
and ADD/WO children. Twenty children with ADD/Hand 15 
children with ADD/WO were identified on the basis of 
DSM-III criteria from a large elementary school population. 
The ADD/WO group obtained IQ scores in the average range 
and did not differ significantly from a control group, 
whereas the children with ADD/H obtained significantly 
lower Full Scale and Verbal IQ scores than the children 
with ADD/WO. Neeper (1985) found no differences in 
cognitive functioning on standardized tests between groups 
of children with ADD/Hand ADD/WO identified by teacher 
rating scales from a population of elementary-school 
children. Lahey et al. (1984) classified 10 children as 
ADD/Hand 20 children as ADD/WO using the Revised Behavior 
Problem Checklist from a non-clinic referred population. 
It was found that both ADD groups exhibited depression and 
low self-esteem. In a review of the ten existing studies 
of ADD/WO, Carlson (1986) suggested that the two ADD 
subtypes display different patterns of behavior. According 
to Carlson, children with ADD/WO typically display poor 
academic functioning, poor peer relationships, 
sluggishness, drowsiness, anxiety, shyness, social 
withdrawl, and do not have conduct problems. Children with 
ADD/H, like children with ADD/WO also display poor academic 
functioning. However, children with ADD/H typically 
display more aggression and conduct disorders. Carlson 
suggested that the evidence indicates that they are 
separate and distinct disorders. 
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However, there are several methodological limitations 
in the above mentioned research (Carlson, 1986). One 
limitation of this research is that many of the studies 
drew their samples from subjects who were experimentally 
identified by ratings on teacher rating scales rather than 
from clinical populations in which subjects have been 
referred because of behavior problems. Of the ten studies 
reviewed, only two studies used clinical populations and 
both of these diagnosed children based on retrospective 
judgements of patient records (Edelbrock, Costello, & 
Kessler, 1984; Maurer & Stewart, 1980). The other studies 
(Carlson et al., 1987; King & Young, 1982; Lahey et al., 
1984; Lahey, Schaugency, Frame, & Strauss, 1985; Neeper, 
1985; Pelham, Atkins, & Murphy, 1981; Sergeant & Scholten, 
1985a and 1985b) experimentall~ identified their subjects. 
Also, overall there were few ADD/WO subjects in these 
studies. These are important limitations to consider. 
Prospective studies using clinical populations and adequate 
sample sizes would provide more meaningful and clinically 
relevant information for clinicians and provide a clearer 
clinical description of the disorder. Further research is 
needed to better clarify the characteristics of children 
with ADD/Hand ADD/WO in order to provide information on 
whether there are two subgroups of one disorder or two 
different disorders. 
Most research investigating ADD published following 
the DSM-III, has failed to specify ADD/Hand ADD/WO 
subtypes (Lahey et al., 1984). Several studies have 
demonstrated an overlap between ADD and conduct disorders 
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(Lahey et al., 1985; Shapiro & Garfinkel, 1986; Steinhausen 
& Gobel, 1985; Stewart et al., 1981; Trites & Laprade, 
1983). For example, Shapiro and Garfinkel (1986) 
identified 2.3% of their sample of 315 nonreferred 
elementary school children to be pure ADD (i.e., ADD 
without any other diagnosable disorders present as defined 
by the DSM-III) and 3% to have ADD and conduct disorders 
(as defined by the DSM-III) using structured interviews and 
teacher rating scales. Other studies have demonstrated an 
overlap of ADD and affective disorders (e.g., depression, 
bipolar disorders) (Biederman et al., 1987; Bohline, 1985; 
Carlson & Cantwell, 1980; Steinhausen & Gobel, 1985). 
Biederman et al. (1987) investigating the incidence of 
affective disorders in ADD children and their families 
using structured interviews of ADD children and their 
parents, determined that 32% of children identified as ADD 
also demonstrated having an affective disorder and 31% of 
their parents had affective disorders. The associated 
problems identified are quite dissimilar and may be a 
result of the heterogeneous nature of the samples studied. 
By studying more homogeneous populations as specified in 
the studies of ADD/WO or UADD, a clearer picture of the 
clinical characteristics of this disorder is developing. 
In summary, the 1980 DSM-III category of ADD has been 
revised to attention deficit-hyperactivity disorder in the 
DSM-III-R because of a lack of sufficient research 
evidence supporting the DSM-III category of ADD/WO 
(Barkley, 1987). The DSM-III-R provides for a separate 
category of undifferentiated-attention deficit disorder 
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(UADD). Individuals manifesting behavior that would have 
been categorized in the DSM-III as ADD/WO would be included 
in the UADD category. It is stipulated in the UADD 
description in the DSM-III-R (American Psychiatric 
Association, 1987) that future research is needed to 
determine the validity of this category. 
Prevalence/Incidence 
The incidence of attention deficit disorders varies 
depending upon the method of determination. Prevalence 
rates for hyperactivity have varied, ranging from 3 to 20% 
of the school-age population (Whalen & Henker, 1976). 
Trites and Laprade (1983) found a prevalence rate of 5 . 7% 
while the rate found by Trites et al. (1979) was 
14 . 3%. Lambert, Sandoval, and Sassone (1978) examined the 
prevalence of hyperactivity as a function of "social system 
definers" and found a prevalence rate of 12.67 % when rated 
by either teachers, parents, or physicians, but when 
consensus by all three was required, the rate was only 
1.19%. 
Additionally, prevalence rates vary as a function of 
gender, culture, and socioeconomic status. Hyperactivity 
and attentional deficits have been reported to occur more 
frequently in boys than girls by a ratio of approximately 
6:1 (American Psychiatric Association, 1987; Trites et al., 
1979) and more often and to a greater severity in lower 
socioeconomic populations (Loney, Langhorne, & Paternite, 
1978). The fluctuation in reported incidence is a function 
of the defining criteria, instruments used to make 
19 
diagnosis, and sample heterogeneity, thus making 
comparisons between studies difficult, if not impossible, 
because of the inconsistencies (Shapiro & Garfinkel, 1986). 
Diagnosis and Assessment 
The diagnosis and assessment of AD-HD is quite 
difficult because of the lack of consensus concerning the 
definition of the disorder and the lack of a critical 
diagnosistic test. Barkley (1981) in reviewing over 200 
studies on hyperactive children found that 70% of the 
studies failed to use objective or specifiable criteria for 
diagnosing individuals as hyperactive. Such 
inconsistencies make it difficult to compare results from 
various studies. 
Clinicians and researchers in the field, suggest that 
a comprehensive evaluation is needed to obtain the 
necessary data in order to diagnose children as AD-HD 
(Cantwell, 1987, Barkley, 1987). such data include 
information regarding the pregnancy and delivery of the 
child, the child's developmental and medical history, and 
the child's problem behavior. This information can be 
obtained through a variety of means including parent 
interviews, medical history questionnaires, child 
observations, behavior rating scales completed by parents 
and teachers, physical and neurological screening exams, 
and other assessment instruments such as tests of cognitive 
abilities. Surprisingly, simple measures of attention have 
not been included typically in test batteries of child 
psychologists or child neuropsychologists (Plaisted, 
Gustavson, Wilkening, & Golden, 1983; Rosenberg & Beck, 
1986; Rourke, 1981). Below is a discussion of some of the 
more commonly used measures of attention in children. 
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Behavior rating scales. Behavior rating scales are 
commonly used to assess children's behavior. The 
advantages of behavior rating scales are: (a) that they are 
able to evaluate several dimensions of behavior in a short 
period of time, (b) that they provide information 
concerning the child's behavior within the natural 
environment without expensive and time-consuming direct 
observations, (c) that they assess significant others' 
perspectives concerning the child, (d) that comparisons of 
the child to his age-related peers can be performed 
statistically, and (e) that ratings can be obtained 
repetitively over time to assess progression and treatment 
effects. The limitations of rating scales are (a) that 
they are dependent upon the ratings of significant others 
and that the biases of the rater can not be controlled, (b) 
that there are limited dimensions assessed and other 
meaningful information may be excluded, and (c) the 
meanings of individual items may not be clearly defined 
(Barkley, 1988). Some of the more common behavior rating 
scales used include the Conners Rating Scales and the Child 
Behavior Checklist. The Conners scales are the most widely 
used rating scales for attention. There are both parent 
and teacher versions. The Conners Parent Rating Scale 
(CPRS; Conners, 1969) consists of items of various behavior 
problems in children. Each item is scored on a 4-point 
severity scale (not at all= O, just a little= 1, pretty 
much= 2, very much= 3). The Revised Parent Rating Scale 
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(Goyette, Conners, & Ulrich, 1978) reduced the scale's 
length. Factor analysis revealed a factor pertaining to 
inattention, hyperactivity and impulsivity, but did not 
suggest a factor for inattention separate from the other 
disruptive behaviors. The Conners Teacher Rating Scale 
(Conners, 1969) consists of items reflecting behavior and 
learning problems. It too is scored on the same 4-point 
severity scale. Factor analytic studies on this scale do 
load on a single dimension of Inattentive-Passive, unlike 
the parent version. Both have satisfactory reliability and 
validity (Barkley, 1987) and are sensitive to stimulant 
drug effects (Cantwell & Carlson, 1978). 
The Child Behavior Checklist (CBCL; Achenbach & 
Edelbrock, 1983) is a rating scale to assess the presence 
of child psychopathology and social competence. There are 
both parent and teacher versions. Items are scored on a 
3-point scale (not at all= o, a little= 1, very much= 2) 
making up various scales that vary with age and gender. 
The parent form comprises a scale labeled Hyperactive 
consisting of items assessing inattention, impulsivity, and 
overactivity but does not discriminate between deficits 
solely related to attention. The teacher form has a scale 
labled Inattention and another labelled Nervous-Overactive 
(which can be used to distinguish between ADD/Hand 
ADD/WO). Both have very good reliability and validity 
(Achenbach & Edelbrock, 1983). 
Cognitive measures. Many psychometric devices have 
been developed to assess attention. However, it has been 
difficult to devise instruments that measure pure attention 
exclusive of other neuropsychological functions. Further, 
there are questions as to the relationship of the various 
measures of attention to children's attentional abilities 
within a natural setting. 
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Various continuous performance tasks are available 
which are designed to assess attentional skills. 
Essentially, these tasks involve the flashing of muliple 
stimuli to the child and the child is to respond only to 
one particular stimulus while inhibiting responses to other 
stimuli. Most tasks last between 10 and 15 minutes. 
Measures of correct responses, errors of commission 
(impulsivity), and errors of omission (inattentiveness) are 
obtained. Continuous performance tasks have been 
demonstrated to discriminate between individuals diagnosed 
as ADD and individuals identified as normal and to be 
sensitive to treatment effects (Douglas , 1983; Swanson & 
Kinsbourne, 1979). 
The Matching Familiar Figures Test (MFFT; Kagan, 
Rosman, Day, Albert, & Phillips, 1964) is the most widely 
used measure of impulsivity. This test involves the 
simultaneous presentation of a sample visual stimulus 
(e.g., person), five similar stimuli, and one stimulus 
identical to the sample stimulus. The child is instructed 
to point to the stimulus that matches the sample. Time to 
first response and number of errors are recorded for 12 
trials. Normative data are available for ages 5 through 
12 for both males and females (Salkind & Nelson, 1980). 
The MFFT has been demonstrated to be quite sensitive to 
stimulant medication effects (Barkley, 1977b; Cantwell & 
Carlson, 1978). 
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Another measure of attention is the Freedom From 
Distractibility factor score (FFD) from the Wechsler 
Intelligence Scale for Children-Revised (WISC-R). Kaufman 
(1975) conducted a factor analysis of the WISC-Rand 
established three factors associated with three cognitive 
constructs thought to be assessed by the WISC-R. The FFD 
factor consists of the Arithmetic, Digit Span and Coding 
subtests and is believed to measure distractibility and 
attention. There is contradictory evidence as to whether 
the FFD discriminates between children with ADD and normal 
children (Brown & Wynne, 1982; Milich & Loney, 1974). 
Because these tasks involve more complex neuropsychological 
processes including short-term memory, calculation 
ability, visuospatial constructional skills, flexibility of 
thought and psychomotor speed than purely attention, 
caution in interpreting the FFD has been suggested (Ownby & 
Matthews, 1985). 
Direct observational techniques have been utilized in 
assessing attentional deficits and treatment effects in 
children (Barkley, 1988). Recording of on-task and 
off-task behavior in the classroom or using observation 
booths with one-way mirrors are some methods of assessment. 
More elaborate recording may include the coding of 
different types of off-task behaviors (e.g., vocalizations, 
fidgetiness, out-of-seat, etc.) as well as distinguishing 
between on-task and off-task behavior. Such methods are 
limited by the lack of normative data to establish levels 
of deviant hyperactive/attention behavior (Barkley, 1988). 
Etiology 
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The diversity of descriptors for AD-HD and the 
confusion over the definition of the disorder reflects the 
uncertainty concerning its etiology. Various theories have 
been proposed to account for the disorder including 
genetic, organic, environmental and psychosocial 
hypotheses. 
Historically, the cause was considered to be some form 
of brain damage, however, this hypothesis has been somewhat 
weakened since less than 5% of children with brain damage 
exhibit hyperactive behaviors (Cantwell, 1982; Routh, 
1978). It is possible that some children diagnosed as 
hyperactive do have brain damage that is the cause for the 
excessive motor activity. There appears to be some 
tentative evidence to suggest the existence of a genetic 
component to AD-HD. Family studies have found a higher 
prevalence rate of hyperactivity in parents and 
second-degree relatives of children diagnosed as 
hyperactive (Cantwell, 1972; Morrison & Stewart, 1971) and 
that there is a greater occurence of hyperactivity in 
siblings of those who were labelled hyperactive as children 
(Boreland & Heckman, 1976). 
The monoamine hypothesis (Garfinkel & August, 1987; 
Wender, Epstein, Kopin, & Gordon, 1971) proposes that the 
disorder is a result of possible brain metabolism 
abnormalities, specifically lower levels of dopamine and 
noradrenaline in those who are hyperactive. Proponents of 
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the monoamine hypothesis are of the opinion that stimulants 
such as methylphenidate and dextroamphetamine function to 
inhibit catecholamine reuptake by the presynaptic neuron, 
increase release of norepinephrine and dopamine into the 
extraneuronal space, and are inhibitors of monoamine 
oxidase (Zametkin, Rapoport, Murphy, Linnoila, and Ismond, 
1985), thereby ameliorating hyperactive symptoms. 
Single photon emission computed tomography studies 
have found hypoperfusion (reduced cerebral blood flow) in 
the periventricular structures, particularly the right 
striatal region (caudate nucleus and putamen), and 
hyperperfusion in the primary sensory and sensorimotor 
regions in children with AD-HD (Lou, Henriksen, Bruhn, 
Borner, & Nielsen, 1989; Lou, Henriksen, & Bruhn, 1984). 
Further, it was found that methylphenidate increased 
cerebral blood flow to striatal and posterior 
periventricular regions and tended to decrease 
flow to primary sensory regions. The evidence of 
hypoperfusion in the periventricular regions is consistent 
with the hypothesis that early hypoxic-ischemic events 
could play a role in the development of attentional 
deficits in children (Lou, 1980). 
Probably the most publicized and controversial 
explanation proposed for hyperactivity has been that of 
Feingold (1976). Feingold has stated that food additives 
and sugars in genetically predisposed children produce 
toxic reactions of cerebral irritability and associated 
behavioral symptoms of hyperactivity and suggested that 
implementation of a highly regimented diet would ameliorate 
the symptoms. Early empirical evidence tended not to 
support the diet's efficacy with the exception of a small 
percentage of children diagnosed as hyperactive (Conners, 
Goyette, Southwick, Lees, & Andrulonis, 1976; Kavale & 
Forness, 1983; Lipton, Nemeroff & Mailman, 1979, Sobotka, 
1978; Wender, 1986). However a few recent studies have 
supported the Feingold hypothesis (Egger, Carter, Graham, 
Gumleys, & Soothill, 1985; Swanson & Kinsbourne, 1979; 
Weiss et al., 1980). Certain methodological differences 
between earlier and later studies may provide reasons for 
the conflicting experiemental results (Lester & Fishbein, 
1988). Previous studies used rather small doses and 
behavioral rating scales, whereas the later studies used 
larger challenge doses and paired associate learning tasks 
to measure sensitivity. Later studies suggest that food 
additives may be implicated in some attention deficit 
disorders. 
Other suggested causative factors in AD-HD include 
food allergies (Varley, 1984), fluorescent lighting 
(O ' Leary, Rosenbaum, & Hughes, 1978; Ott, 1974), lead 
poisoning (David, 1974), prenatal and perinatal factors 
(Denson, Nansen, & Mcwatters, 1975), academic failure 
(Cunningham & Barkley, 1978), and increased cultural tempo 
(Block, 1977). 
At best, it can be concluded that there has been no 
demonstrated single etiology to explain hyperactivity, 
which is not surprising given the heterogeneous nature of 
the disorder. The empirical findings using computed 
tomography suggesting hypoperfusion of the periventricular 
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structures and hyperperfusion of the primary sensory and 
sensorimotor regions point to a promising future direction 
in the investigation of the origins of attentional 
deficits. The focus of etiological research is shifting 
from identifying single causative determinants to an 
interactionist position that proposes multiple etiological 
factors (Porges & Smith, 1980). Conners and Wells (1986) 
summarizing the current state of research on AD-HD and 
identifying directions for further research state, 
until one knows how to classify subjects 
into homogeneous groups there is no hope of finding 
either unique biological or environmental causes, 
to say nothing of the transactional causative 
networks that, in the final analysis, are the 
most likely explanatory systems for such complex 
behavioral manifestations. (p. 24) 
Fortunately, knowledge of etiology is often not required 
for treatment. Organic disorders do not, always, preclude 
response to psychological treatment, nor do disorders of 
psychogenic etiology always fail to respond to 
pharmacological treatment. 
Outcome/Prognosis 
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It was previously thought that symptoms of 
hyperactivity diminished with the onset of puberty 
(Boreland & Heckman, 1976). Present research suggests that 
behavioral and cogntive symptoms persist well into 
adolescence and adulthood (Hechtman, Weiss, Perlman, & 
Tuck, 1981; Klee, Garfinkel, & Beauchesne, 1986; Weiss & 
Hechtman, 1986). Also, secondary problems of poor 
self-esteem, aggressiveness, academic difficulties, poor 
peer interactions, depression, and antisocial behavior are 
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exibited more as children with ADD move into adolescence. 
From longitudnal studies of children diagnosed as ADD, it 
has been found that there is an association between 
childhood ADD and delinquency and antisoical behavior in 
adolescents (Huessey, Metoyer, Townsend, 1974; Weiss, 
Hechtman, Perlman, Hopkins, & Wener, 1979) and 
psychopathology in adults (Cantwell, 1972; Mendelson, 
Johnson, & Stewart, 1971). Also, studies of family members 
of children with hyperactivity indicate an increased risk 
of alcoholism, sociopathy, and somatization disorder in the 
biological parents of hyperactive children and also that a 
high percentage of these parents were previously diagnosed 
as hyperactive (Cantwell, 1972; Morrison & Stewart, 1971). 
Cantwell found that 10% of the parents of children with 
hyperactivity were formerly hyperactive and all of these 
had psychiatric problems as adults. Morrison and Stewart 
found that 30% of their hyperactive population had parents 
who were hyperactive and 70% of these parents had 
psychiatric problems. 
Treatment 
Since AD-HD is a heterogeneous disorder of unknown 
etiology, it is unlikely that any one therapuetic 
approach would be successful in all cases. Multimodal 
treatment approaches have been found to be most successful 
in the management of AD-HD (Cantwell, 1982; Weiss & 
Hechtman, 1986). Parent training in child management 
skills, environmental modifications, special education, 
social skills training, individual counseling for older 
children and adolescents with ADHD, psychopharmacological 
intervention and biofeedback have been proven to be useful 
in the short-term for some individuals but no long-term 
efficacy has been demonstrated (Ross & Ross, 1982). 
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Psychoactive stimulants have been widely used since 
the mid-1930's to treat hyperactivity as well as other 
childhood disorders. Stimulants are now the most common 
treatment for hyperactive children to manage their behavior 
problems (Barkley, 1981). Three psychostimulant medications 
have been commonly used in treating AD-HD: 
dextroamphetamine (Dexadrine), methylphenidate (Ritalin), 
and Pemoline (Cylert). Stimulants are sympathomimetic 
agents that increase the arousal or alertness of the 
central nervous system. The primary mode of action of 
methylphenidate and ct-amphetamine is believed to be one of 
increasing catecholamine activity in the CNS, by increasing 
the availability of the catecholamines at the synaptic 
cleft. Both dopamine and norepinephrine are believed to be 
effected. The mechanism of pemoline is not clear. The 
site of action within the CNS of stimulants is not clear as 
well, although it is suggested that the brain stem or 
frontal cortex is involved (Barkley, 1981). Estimates are 
that .6% to 1% of school-age children are receiving 
stimulants (Sandoval, Lambert & Sassone, 1980). 
Many well-designed studies have demonstrated the 
efficacy of stimulants in the treatment of AD-HD. Several 
comprehensive reviews (Kavale, 1982; Rapoport, 1983; 
Thurber & Walker, 1983) concluded that 70-75% of children 
with ADD/H respond positively to stimulant medication on 
one or more measures of drug efficacy such as rating 
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scales, observed and quantitative motor activity, cognitive 
and perceptual tests, detection of speech in background 
noise, speech fluency, handwriting, EEG and evoked 
potentials, peer perceptions, and academic performance 
(Conners & Wells, 1986). However, problems have been 
identified in the use of stimulants including their short 
half-life, retardation of weight and height (Garfinkel, 
1986), lack of long-term benefits on school performance and 
frequent side effects such as insomnia, anorexia, and 
irritability (Barkley, 1977a). Very few studies have 
investigated the long-term effects of stimulants on 
hyperactive children, with generally negative results found 
(Barkley, 1981). 
Antidepressant medications have also been found to be 
effective in the treatment of with hyperactivity, 
particularly with children identified as hyperactive with 
depressive symptoms. Imipramine (Tofranil) has been the 
antidepressant most widley studied with children diagnosed 
as hyperactive (Barkley, 1981). 
Several studies have addressed the question whether 
stimulant medication, behavior therapy, or a combination is 
the best treatment approach. Barkley (1981) reviewing the 
literature concluded that behavior therapy alone is not as 
effective as stimulant medication in managing hyperactive 
and disruptive behavior and combined approaches were most 
beneficial. 
There have been no studies published to date that have 
sought to determine whether stimulant medication is an 
effective treatment with children diagnosed with UADD (or 
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the previous diagnostic category of ADD/WO). Given the 
possible differing clinical pictures of children with ADD/H 
and ADD/WO and the uncertainty of the diagnostic category 
of UADD, it may be that the treatment needs of children 
with UADD or ADD/WO may be different from the treatment 
needs of children with AD-HD, therefore requiring 
alternative treatment interventions. Research is needed to 
determine the characteristics and treatment needs of 
children with UADD and whether stimulant medication is an 
effective treatment for these children. 
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CHAPTER III 
METHOD 
In this study, the intellectual, behavioral, and 
affective characteristics and responses to stimulant 
medication of children with AD-HD and UADD were examined to 
determine the differences, if any, between these two 
groups. 
Subjects 
This study involved 17 children diagnosed as having an 
undifferentiated-attention deficit disorder (UADD) and 19 
children diagnosed as having an attention deficit-
hyperactivity disorder (AD-HD). The UADD sample was 
composed of 16 males and 1 female with a mean age of 10 
years. The AD-HD sample was composed of 14 males and 5 
females with a mean age of 9. A Fisher's Test for 2 X 2 
indicated no significant difference in gender between the 
two groups (p = .11542). An unpaired t-test revealed a 
significant difference in age between the two groups (see 
Table 1) . 
Table 1 
T-test Analysis of Mean Ages and Standard Deviations 
for UADD and AD-HD Groups 
*P < .05 
UADD 
(n = 11) 
10.00 
1. 32 
AD-HD 
(n = 19) 
9.00 
1. 52 
T-value 
2.09* 
Subjects were clinical patients recruited from 
referrals to (a) the Developmental Center for Handicapped 
Persons, Clinical Services Unit, Utah State University 
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(n = 31); (b) the University-Affiliated Center, University 
of Texas Southwestern Medical School at Dallas 
(UTSMSD) (n = 2); (c) ADD Associates, Dallas, Texas (n = 2); 
and (d) the Neuropsychiatry Psychopharmacology Clinic, 
Children's Medical Center (CMC) at Dallas (n = 1). The 
only subjects included in the study were as follows: (a) 
Subjects who were diagnosed as having either AD-HD or UADD 
by three independent raters (i.e., pediatrician, 
psychiatrist, psychologist, and psychology intern; (see 
Table 2) according to the Diagnostic and Statistical Manual 
of Mental Disorders- Third Edition-Revised (DSM-III-R) 
criteria, (b) Subjects for whom informed parental 
consent for participation in the study was obtained (see 
Appendix A), and (c) Subjects who were recommended for 
treatment with stimulant medication were included in the 
study. Diagnoses were made on the basis of comprehensive 
evaluations including developmental and medical history, 
physical and neurological screening exams, and 
psychoeducational evaluations . Interrater agreements for 
the various settings were determined by determining the 
percentage of cases in which all three of the raters agreed 
on the same diagnosis (see Table 3). There was agreement on 
31 of 34 subjects on ratings by a pediatrician, 
psychologist, and psychology intern at the DCHP; 2 out of 
2 subjects on ratings by a pediatrician, psychologist, and 
and psychology intern at ADD Associates; and 1 out of 3 
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Table 2 
Raters' Qualifications by Site 
Site 
DCHP 
UT SMC 
ADD 
Assoc. 
Rater 
Psychologist 
Qualifications 
10+ years experience in the 
treatment and research on children 
with attentional problems, learning 
disabilities, developmental 
disabilities, and behavior disorders 
Pediatrician 6+ years experience in the treatment 
and research on children with 
attentional problems, learning 
disabilities, developmental 
disabilities, and behavior disorders 
Psychology trained in the diagnosis and 
Intern treatment of children with 
attentional problems, learning 
disabilties, developmental 
disabilities, and behavior disorders 
Pediatrician 15+ years experience in the 
treatment and research on children 
with attention problems and 
developmental disabilities, 
Pediatric 
Fellow 
Psychology 
Fellow 
1+ years experience as a 
pediatrician for a 
university-affiliated clinic 
for children with attention 
problems, learning disabilities, 
developmental disabilities, and 
behavior problems 
5+ years experience in the diagnosis 
and treatment of children with 
attentional problems, learning 
disabilities, developmental 
disabilities, and behavior problems 
Psychologist 3+ years experience in the treatment 
and research on children with 
attentional problems and behavior 
disorders 
Pediatrician 10+ years experience in the 
diagnosis and treatment of children 
with attentional problems 
(table continues) 
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T,ble 2 (continued) 
R,ters' Qualifications by Site 
s .te Rater Qualifications 
Psychology 5+ years experience in the diagnosis 
Fellow and treatment of children with 
attentional problems, developmental 
disabilities, learning disabilities, 
and behavior problems 
CIC Psychiatrist 3+ years as child psychiatrist in 
clinic for children with 
attention-deficit disorder 
Psychologist 5+ years experience in the diagnosis 
and treatment of children with 
behavioral and emotional problems 
Psychology 5+ years experience in the diagnosis 
Fellow and treatment in children with 
attentional problems, learning 
disabilities, developmental 
disabilities, and behavior problems 
Table 3 
Number of Potential AD-HD and UADD Subjects and Interrater 
Agreement Between Independent Raters Among Sites 
Site n 
potential 
subjects 
DCHP 34 
UT SMC 2 
ADD Assoc. 2 
Total 41 
n 
agreement 
31* 
2* 
2* 
36* 
* subjects included in the study 
n 
non-agreement 
3 
0 
0 
5 
~ 0 
91 
100 
100 
88 
subjects at CMC. Approval for the study was obtained from 
the Utah State University Human Subjects Review Board (see 
Appendix B) and the University of Texas Southwestern 
Medical Center at Dallas Institutional Review Board (see 
Appendix C) . 
Procedures 
A pretest-posttest experimental design (Campbell & 
Stanley, 1963) was used to determine the cognitive and 
affective characteristics of children with AD-HD and UADD, 
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and to determine their long-term response to stimulant 
medication. Subjects from both groups were administered a 
battery of instruments prior to initiation of treatment 
including measures of intelligence, impulsivity, 
self-reported depression and self-esteem. The battery was 
readrninistered, with the exception of the intelligence 
scales, three months after treatment. Parents and teachers 
were asked to complete behavior rating scales of attention 
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and problem behavior before and three months after 
treatment. Five UADD subjects and seven AD-HD were not 
included from the above mentioned sample for the treatment 
portion of the study for various reasons including (a) 
parental choice to forego psychopharmacological 
intervention (UADD = 1, AD-HD= 1), (b) adverse side 
effects (UADD = 1, AD-HD= 1), (c) noncompliance to 
medication treatment (AD-HD= 1), (d)dropped out for 
unknown reasons (UADD = 1, AD-HD= 1), and (e) identified 
and placed on medication prior to initiation of treatment 
study (UADD = 2, AD-HD= 3). A total of 12 AD-HD subjects 
(n = 11 males, n = 1 female; mean age= 8.9) and 12 UADD 
subjects (n = 8 males, n = 4 females; mean age= 9.8) 
completed the treatment phase and were included in the 
pretest and posttest analyses. There was not a significant 
difference between the two groups in gender (Fisher's Test 
for 2 X 2,-12 = .15839) or age (t = 1.46, Q = .1567). 
Materials 
The battery of instruments included the following: 
1. Wechsler Intelligence Scale for Children-Revised 
(WISC-R; Wechsler, 1974). The WISC-R is the most widely 
administered intelligence test for school-age children, 
ages 6-16, with excellent psychometric properties (Sattler, 
1982). Reliability and validity information is provided 
within the test manual. Average split-half coefficients 
for the verbal, performance, and full scale scores are 
reported to be .94, .90, and .96, respectively. Concurrent 
validity has been demonstrated comparing the WISC-R with 
the 1972 norms of the Stanford-Binet Intelligence Scale 
(Form L-M) reporting a coefficient of .73. The WISC-R is 
given to evaluate cognitive and problem-solving abilities 
and can also provide information regarding attention 
deficits. The Freedom From Distractibility Index (FFD), 
consisting of the digit span, arithmetic, and coding 
subtests and derived from factor analysis (Sattler, 1982), 
has been used as a indice of attentional deficits (Lufi & 
Cohen, 1985; Wynne, 1979). Children from the two groups 
were compared based on the Full Scale IQ, Verbal IQ, and 
Performance IQ scores as well as the Freedom From 
Distractibility Index scores. 
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2. Piers-Harris Self-Concept Scale ("The Way I Feel 
About Myself") (Piers, 1984). This is a self-report 
instrument designed to measure a child's self-perceptions 
concerning his self-image, school performance, body image, 
and interpersonal relationships. It involves a series of 
80 first-person declarative statements, to which the child 
responds "yes" or "no". It yields an overall self-concept 
score and six subscale cluster scores (Behavior, 
Intellectual and School Status, Physical Appearance and 
Attributes, Anxiety, Popularity, and Happiness and 
Satisfaction), which can be converted to percentiles, 
stanines, and T- scores. It was standardized on a sample of 
1,183 children in grades 4 through 12. It has been widely 
used in clinical and research practices and is suggested 
for use with children 8-18 years of age. Test-retest 
reliability coefficients range from .42 to .96 with a 
median coefficient of .73. Construct validity correlations 
with other self-report self-concept measures range from .32 
to .85. Additional reliability and validity data are 
available in the test manual (Piers, 1984). 
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3. Children's Depression Inventory (CDI; Kovacs, 
1985). The Children's Depression Inventory (see Appendix 
D) is the most commonly used self-report questionnaire for 
assessing depressive symptoms in children and adolescents. 
It consists of 27 items that assess the presence and 
severity of affective, cognitive, motivational, 
vegetative, and psychomotor components of depression. Each 
item consists of three statements relating to severity 
levels of a depressive symptom, rated from Oto 2. The 
child chooses the statement which best describes himself or 
herself over the past 2 weeks. High scores indicate high 
levels of self-reported depression. Reliability data on 
the CDI is acceptable with an internal consistency 
coefficient of .82 and a test-retest coefficient of .82. 
Concurrent validity of the CDI was determined against two 
self-report measures, the Revised Children's Manifest 
Anxiety Scale (Reynolds & Richmond, 1978) and the 
Coopersmith Self-Esteem Inventory (Coopersmith, 1967). 
The correlation between the depression and anxiety scales 
was highly significant (~ .65, 2 < .0001); self-rated 
depressive symptomatology and low self-esteem were also 
correlated (L = -.59, 2 < .0001). Additional 
reliability and validity data have been reported which 
showed that the CDI could be used as an index of the 
severity of depression and a measure of change as a result 
of treatment intervention (Kovacs, 1985). No age-related 
normative data is available. 
4. Matching Familiar Figures Test (MFFT; Kagan, 
1964). The MFFT has been widely used as a measure of 
impulsivity. On this instrument, the child is presented 
with a stimulus picture on one page and six pictures on 
another page, five which are slightly different and one 
which is exactly the same as the stimulus picture. The 
child is instructed to find the picture which is the same 
as the stimulus picture. Response times and errors are 
scored. The MFFT has been found to differentiate between 
children identified as hyperactive and children considered 
normal on the construct of impulsiveness (Quay & Brown, 
1980). No validity or reliability data is provided within 
the test manual. Messer (1976) reported convergent 
validity correlations on the MFFT response times and 
errors to be .73 for response time and .68 for errors 
obtained. 
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5. Conners Parent Rating Scale-Revised (CPRS-R; 
Conners, 1969) and Conners Teacher Rating Scale (CTRS; 
Conners, 1973). The CPRS-R (see Appendix E) and CTRS (see 
Appendix F) have been extensively employed in both clinical 
and research practices (Brown , 1982; Garfinkel & Klee, 
1986) in the assessment and diagnosis of attention deficit 
disorders, and to measure treatment effects. It provides 
indices of hyperkinesis, conduct problems, and anxiety. 
T-scores for the hyperkinesis index were compared on both 
the parent's (mother) and teacher's form for children in 
both samples for this study. Normative data is available 
for sex and ages 3-17 years (Goyette, Conners, & Ulrich, 
1978). Test-retest reliability for the CTRS ranges from 
.70 to .90 {Conners, 1973). No validity data has been 
reported on the CPRS-R. 
6. Child Behavior Checklist {CBCL; Achenbach & 
Edelbrock, 1983). The CBCL is a questionnaire used to 
assess the behavioral problems and adaptive social 
competencies of 4 to 16 year old children. Both parent 
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and teacher versions are available. The Parent Form 
consists of 118 items related to behavior problems on which 
the parent rates the child using a 3-point scale ("not 
true," "somewhat or sometimes true," "very true or often 
true"). There are 20 additional social competency items, 
which assess the amount and quality of children's 
activities, social interactions, and school performance. 
Factor analytic studies of the CBCL for males and females 
at ages 4 to 5, 6 to 11, and 12 to 16 for both parents and 
teachers were completed to derive various behavior problem 
scales. Raw scores can be converted to T-scores and 
percentiles. According to the test manual, children of 
different ages and sex can be compared on similar scales. 
Test-retest reliability ranges from .61 to .92. Construct 
validity correlation coefficients with the Revised Behavior 
Problem Checklist range from .71 to .92. More detailed 
reliability and validity data including criterion-related 
validity and discriminant analysis are provided in the 
instrument's manual {Achenbach & Edelbrock, 1983). 
Treatment 
Subjects from both samples received methlyphenidate 
(Ritalin) 0.3 mg/kg/dose given twice daily. Compliance was 
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monitored by the prescribing of one-month allottments of 
medication and requiring the parents to call the physician 
for additional prescriptions. Noncompliance (AD-HD= 1, 
UADD = O) was suspected if parents failed to contact the 
physician for renewal of their prescription after the one-
month allottment would be expected to have run out, or if 
the physician was contacted for renewal of the prescription 
prior to when the allotment of medication was expected to 
have run out. 
Data Analysis 
Unpaired t-tests were performed to determine the 
differences between UADD and AD-HD subjects on measures of 
intellectual functioning, impulsivity, parent- and 
teacher-rated behavior, self-reported depression, and 
self-esteem prior to treatment. Paired t-tests were 
computed on pretest and posttest measures of impulsivity, 
self-reported depression and self-esteem, and parent and 
teacher-rated behavior for each group to determine their 
response to stimulant medication. A repeated measures 
ANOVA was used to determine the differences between the two 
groups in their response to stimulant medication on 
measures of impulsivity, self-reported depression and 
self-esteem, and parent and teacher-rated behavior. 
CHAPTER IV 
RESULTS 
The intent of this study was to improve our 
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nderstanding of the clinical characteristics and treatment 
of children with AD-HD and UADD. Two specific objectives 
and related hypotheses were addressed in this study. The 
results are discussed below. 
Objective 1 
The first objective of this study was to identify the 
cognitive and affective characteristics of children 
diagnosed as AD-HD and UADD and determine the differences, 
if any, between these children. Seventeen children 
diagnosed as UADD and 19 children diagnosed as AD-HD were 
c ompared on measures of intelligence, impulsivity, problem 
behavior, depression, and self-esteem in order to clarify 
the clinical characteristics of these disorders. The null 
ypothesis tested was: (a) There will be no significant 
difference (Q < .05) between children with AD-HD and 
children with UADD on intelligence scores, measures of 
impulsivity, parent and teacher ratings of problem 
behavior, or self-reported depression or self-esteem. 
Intellectual functioning. WISC-R Full Scale IQ, 
Verbal IQ, and Performance IQ scores were obtained prior to 
treatment for both UADD and AD-HD groups and compared. 
Kaufman's (1975) Verbal Comprehension, Perceptual 
Organization, and Freedom From Distractibility Index scores 
derived from factor analytic studies were also compared for 
each group. Separate unpaired t-tests were performed to 
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compare the means for each group on each of these cognitive 
variables. The results of the statistical analysis are 
presented in Table 4. No statistically significant 
differences (p < .05) were found between the two groups on 
the Full Scale IQ, Verbal IQ, or Performance IQ scores. 
Also, there were no significant differences found on the 
Verbal Comprehension, Perceptual Organization, or Freedom 
From Distractibility Index scores. These results support 
the aceptance of the null hypothesis . 
Impulsivity. Percentile ranks of the total number of 
errors obtained and mean latency time on the MFFT for UADD 
subjects and AD-HD subjects were compared using unpaired 
t-tests (see Table 5) . There was not a statistically 
significant difference (p < .05) between AD-HD subjects 
(M = 50.94) and UADD subjects (M = 45.82) in the total 
number of errors , t (33) = -0.50. There was also no 
significant difference (p < .05) between AD-HD subjects (M 
20 . 00) and UADD subjects (M = 34.88) in mean latency time 
t (33) = 1.73 . However, there was a difference at p < .10 . 
These results indicate evidence that supports rejection of 
the null hypothesis. 
Depression and self-esteem. CD! total scores were 
compared for both the UADD (M = 11.19) and AD-HD (M = 
13.33) groups using an unpaired t-test. Results are 
presented in Table 6. It can be seen that no statistically 
significant differences (p < .05) were found between the 
two groups, t (32) = -0.74 in self-reported depression. 
These results support acceptance of the null hypothesis. 
Table 4 
Intellectual Functioning: T and p-values for 
Group Mean IO Scores and Standard Deviations 
for UADD and AD-HD Subjects 
IQ Score n 
Full Scale 
UADD 16 97.56 11. 74 -0.18 33 
ADHD 19 98.42 16.50 
Verbal 
UADD 16 94.44 13.16 -0.18 32 
ADHD 18 95.33 16.14 
Performance 
UADD 16 101.63 13.31 0.14 32 
ADHD 18 106.89 16.72 
Verbal Comprehension 
UADD 12 101.67 13.34 0.97 24 
ADHD 14 96.21 15.13 
Perceptual Organization 
UADD 12 102.97 14.18 -0.28 24 
ADHD 14 104.79 18.66 
Freedom From Distractibility 
UADD 12 94.83 13.92 -0.41 24 
ADHD 14 96.86 11. 40 
*12 < • 05 
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.8588 
.8597 
.8874 
.33377 
.7743 
.6919 
Tcble 5 
Inpulsivity: T and p-values for Group Mean 
Percentile Ranks and Standard Deviations on MFFT 
fer UADD and AD-HD Subjects 
,ariable 
liFFT Total 
M 
SD 
NFFT Mean 
M 
SD 
:p < • 05 
UADD 
(!l = 17) 
Errors 
45.82 
27.84 
Latency Time 
34.88 
30.91 
ADHD 
(!l = 18) 
50.94 
32.58 
20.00 
18.06 
.t (33) 
-0.50 
1. 73 
46 
.6196 
.0957 
Additional analysis revealed that five of the 17 UADD 
c hil dren scored above the cut-off ( > 2 Standard Deviations 
a bove the mean) on the CDI, while 10 of the 19 AD-HD 
c l ildren scored above the cut-off. A Fisher's Test for 2 X 
2 was computed revealing no significant difference (p = 
. ~4037) between the two groups (see Table 7). 
Piers-Harris Total Scale T-scores and cluster scale 
T-scores for the six subscales were compared. Unpaired 
.t -tests were computed with results reported in Table 6. No 
s:atistically significant differences (p < .05) were found 
between the two groups. These results support acceptance 
o : the null hypothesis. 
Table 6 
Self-Reported Depression and Self-Esteem: T and 
p-values for Group Means and Standard Deviations 
on the CDI and Piers-Harris for UADD and AD-HD Groups 
Variable 
CDI Total Score a 
M 
SD 
UADD 
(n = 16) 
11.19 
9.12 
ADHD 
(n = 18) 
13.33 
7.72 
Piers-Harris Total T-scoreb 
M 52.50 50.44 
SD 15.65 11. 36 
Behavior Clusterb 
M 45 . 81 44 . 00 
SD 16.05 12.10 
Intellectual and School Statusb 
M 46 . 06 48.89 
SD 13 . 74 8 . 85 
Physical Appearance and Attributesb 
M 50.25 55.28 
SD 11.97 10.06 
Anxietyb 
M 52.06 49.11 
SD 13.41 12.52 
Popularityb 
M 46.13 43.94 
SD 13.47 9 . 60 
Happ i ness and Satisfactionb 
M 48.50 49.83 
SD 12.56 10.14 
*P < .05 
a M = 9, SD= 4 
t (32) 
-0.74 .4674 
0.43 .6678 
0.37 .7154 
-0.70 .4882 
-1. 33 .1976 
0.66 .5134 
0.54 .5951 
-0.34 .7377 
b T-score > 70 indicates significant problem behavior 
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Table 7 
Number of Depressives versus Nondepressives on the 
CDI for UADD and AD-HD Groups Using Fisher's Test 
for 2 X 2 
Depressed 
(CDI>2 standard 
deviations) 
Non-depressed 
(CDI<2 standard 
deviations) 
* p < .05 
UADD 
(n = 17) 
5 
11 
AD-HD 
en= 19) 
10 
8 
.1404 
48 
Problem behavior. Unpaired t-tests were computed to 
determine if there were any statistically significant 
differences in the means between the two groups on the 
Hyperactivity Index T-scores of the CPRS-R and the TBRS 
(see Table 8). No significant difference was found between 
the UADD subjects (M = 63.18) and the AD-HD subjects (M = 
69.29) on the TBRS Hyperactivity Index ( t {32} = -1.44, 
p = .1586). AD-HD subjects (M = 77.74) were rated 
significantly higher than UADD subjects (M = 67.53) by 
their parents on the CPRS-R (t {32} = -2 . 34, p < . 05). 
These results support rejection of the null hypothesis. 
Parent and teacher ratings of problem behavior using 
the CBCL were compared for children with UADD and AD-HD. 
The following problem behavior scales on the parent form 
were of interest because of their clinical and research 
utility in measuring inattention and hyperactivity, 
emotional problems, and conduct problems (Achenbach & 
Table 8 
Parent and Teacher Ratings of Inattention/Hyper-
activity: T and p-values for Group Mean Hyperactivity 
Index T-scores and Standard Deviations on the 
CPRS-R and TBRS for UADD and AD-HD Groups 
Scale n 
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CPRS-Ra 
UADD 
ADHD 
17 
19 
67.53 
77.74 
11. 62 
14.25 
-2.34 34 .0255* 
TBRsa 
UADD 
ADHD 
*12 < .05 
17 
17 
63.18 
69.29 
13.16 
11.49 
-1. 44 32 .1586 
a ~-score> 70 indicates significant problem behavior 
Edelbrock, 1983). On the parent form, the Aggressive, 
Hyperactive, Delinquent, Depression, Social Withdrawl, 
Anxious, and Uncommunicative scales were utilized. The 
Anxiety, Social Withdrawl, Unpopular, Inattention, 
Hyperactive, and Aggressive scales on the teacher form were 
of interest. Mean scale T-scores on the CBCL (parent form) 
were compared for each group using unpaired ~-tests (see 
Table 9). It can be seen that AD-HD subjects were rated 
significantly higher than the UADD subjects on the 
Aggressive, Hyperactive, and Delinquent problem behavior 
scales. There were no significant differences between the 
two groups on the Depressive, Social Withdrawl, Anxious, 
and Uncommunicative problem behavior scales. Some of these 
results (aggressive, hyperactive, and delinquent) support 
rejection of the null hypothesis. 
Table 9 
Parent Ratings of Problem Behavior: T and p-values 
for Group Mean CBCL T-scores and Standard Deviations 
for UADD and AD-HD Groups 
Scale n 
Aggressivea 
UADD 17 62.06 9.83 -3.83 34 
ADHD 19 75.05 10.47 
Hyperactivea 
UADD 16 71. 94 8.90 -2.21 33 
ADHD 19 78.00 7.35 
Delinquent a 
UADD 16 64.19 8.92 1. 99 33 
ADHD 19 70.05 8.46 
Depressiona 
UADD 14 67.07 8.73 6.18 29 
ADHD 17 66.88 8.25 
Social Withdrawla 
UADD 15 66.53 8.80 -9.60 31 
ADHD 18 66.83 9.05 
Anxious a 
UADD 13 64.38 9.26 0.60 23 
ADHD 12 62.58 5.33 
Uncomrnunicativea 
UADD 15 64.27 9.67 5.72 27 
ADHD 14 64.07 8.64 
* Q < .05 
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.0005* 
.0343* 
.0545* 
.9511 
.9241 
.6486 
.9548 
a T-score > 70 indicates significant problem behavior 
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Results of unpaired t-tests were computed to compare 
teacher ratings of problem behavior for UADD and AD-HD 
subjects using the CBCL and are reported in Table 10. No 
statistically significant (2 < .05) differences were found 
on any of the problem behavior scales. These results 
support acceptance of the null hypothesis. 
Overall, the results support acceptance of the null 
hypothesis concerning intellectual functioning, depression, 
and self-esteem. No significant differences (2 < .05) were 
found between the two groups on measures of intellectual 
functioning, self-reported depression or self-esteem. The 
results support the rejection of the null hypothesis that 
there would be no differences between the two groups in 
problem behavior as reported by parents or teachers. 
Parents rated AD-HD subjects as displaying significantly 
more hyperactive, aggressive, and delinquent problem 
behavior than UADD subjects. There were no differences in 
parent-ratings in anxious, social withdrawl, depressive, or 
uncommunicative problem behavior. There were also no 
differences in teacher-ratings of problem behaviors. 
Objective 2 
The second objective of this study was to determine 
the treatment effects of stimulant medication 
(methylphenidate) on UADD and AD-HD children and to 
determine the differences, if any, between the two groups. 
Twelve UADD and 12 AD-HD subjects were compared on measures 
of impulsivity, teacher and parent ratings of problem 
behavior, and self-reported depression and self-esteem, to 
Tab le 10 
Tea~her Ratings of Problem Behavior: T and p-values 
for Group Mean CBCL T-scores and Standard Deviations 
forUADD and AD-HD Groups 
Sc1le n 
Ami et ya 
'JADD 17 59.82 6.82 0.62 32 
-\.DHD 17 58.47 5.93 
So ~ial Withdrawla 
'JADD 17 65.59 8.49 1. 57 32 
.1.DHD 17 59.59 13.32 
Un)opulara 
'JADD 17 63.53 8.41 0.21 32 
!DHD 17 62.94 7.72 
Imttentiona 
tr ADD 14 66.00 5.75 -1. 03 27 
i DHD 15 68.20 5 . 73 
Hyperacti vea 
U"ADD 17 64.06 10.36 -1.17 32 
i DHD 17 67.71 7.65 
Ag ~ressi vea 
'DADD 17 62.24 10.18 -0.94 32 
i.DHD 17 65.12 7.61 
* ! < • 05 
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.5413 
.1272 
.8330 
.3112 
.2519 
.3570 
a :-score> 70 indicates significant problem behavior 
53 
determine their response to stimulant medication. The null 
hypotheses tested were as follows: 
1. There will be no significant differences (n < .05) 
between pretest and posttest measures of impulsivity, 
parent and teacher ratings of problem behavior, and 
self-reported depression and self-esteem for children with 
UADD or AD-HD who received stimulant medication as 
treatment. 
2. There will be no significant differences (n < .05) 
between children with AD-HD or UADD who have received 
stimulant medication as treatment on measures of 
impulsivity, parent and teacher ratings of problem 
behavior, or self-reported depression or self-esteem before 
or after treatment. 
Impulsivity. Two repeated measures two-way analyses 
of variance and post hoc paired t-tests were performed to 
compare pretest and posttest percentile rankings of mean 
latency and total errors scores on the MFFT for UADD and 
AD-HD subjects (see Table 11). In terms of total errors, 
there was no significant difference (p < .05) between the 
two groups in the total errors scores on pretest, E (1,20) 
= 0.52. There was als~ no significant difference between 
pretest and posttest total error scores for either the UADD 
group,_t (20) = 1.47, or the AD-HD group, t (20) = 1.03. 
No significant group X treatment interaction was found, E 
(1,43) = .06. These results support acceptance of the null 
hypothesis. A significant difference was found, E (1,20) = 
5.81, in the mean latency time between the UADD (M = 40.09) 
and AD-HD (M = 17.91) groups. No significant difference (n 
Table 11 
Inpulsivity: F-Ratios, T-Values and p-values for 
G~oup Mean Scores and Standard Deviations on MFFT 
f or UADD and AD-HD Groups 
REPEATED MEASURES ANOVA 
df 
~otal Errors 
Group 1,20 484.454 0.52 .4783 
Treatment 1,20 1223.273 2.51 .1288 
Interaction 1,43 29.454 0.06 .8083 
.n:ean Latency Time 
Group 1,20 6925.097 5.81 .0256* 
Treatment 1,20 2.404 0.00 1.0000 
Interaction 1,43 93 . 090 0.42 .5255 
p < .05 
PAIRED '.!'.-TESTS 
.D. Pre Post t 
M M 
Total Errors 
UADD 11 36.82 27.91 1. 47 . 1721 
ADHD 11 45.09 32.91 1. 03 .3284 
Mean Latency Time 
UADD 11 40.09 43.00 -0.35 .7342 
ADHD 11 17.91 15.00 0.85 .4146 
* p <.05 
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< .05) was found between the pretest and posttest mean 
latency time for either the UADD group, t (20) = -.39, or 
the AD-HD group, t (20) = .85. Also, no significant group 
X treatment interaction (p < .05) was found, E (1,43) = 
.42. These results support acceptance of the null 
hypothesis. 
Depression and self-esteem. Pretest and posttest CDI 
total scores for UADD and AD-HD groups were compared by a 
repeated measures two-way analysis of variance (see Table 
12) and post hoc paired t-tests (see Table 13). There was 
not a significant group X group main effect for mean 
scores, E (1,20) = 0.00, between UADD and AD-HD groups. 
There was a significant treatment main effect, E (1,20) = 
15.77, p < .007, between pretest and posttest scores for 
UADD and AD-HD subjects. Paired t-tests revealed 
statistically significant differences in pretest and 
posttest CDI total scores for both the UADD group, t (10) 
2.8, p < .03 and the AD-HD group, t (12) = 2.82, p < .02. 
Figure 1 graphically shows the change in pretest and 
posttest group mean scores on the CDI for both UADD and 
AD-HD groups. Further, 5 of the five UADD subjects and 5 
out of the six AD-HD subjects who scored above the cut-off 
(CDI Total Score> 2 standard deviations above the mean) 
before treatment scored below the cut-off(< 1 standard 
deviation above the mean) after treatment. A Fisher's Test 
for 2 X 2 revealed no significant differences (p = 
.14037) between the two groups (see Table 14). There was 
no significant group X treatment interaction effect, E 
(1,43) = 0.15, between UADD and AD- HD groups before and 
Table 12 
Self-Reported Depression and Self-Esteem: F-Ratios 
and p-values for Group Mean Scores on CDI and 
Piers-Harris for UADD and AD-HD Groups 
CDI Total Score 
Group 
Treatment 
Interaction 
1,20 
1,20 
1,43 
.221 
664.568 
6.274 
Piers-Harris Total 
Group 
Treatment 
Interaction 
Score 
1,20 
1,20 
1,43 
48.878 
1070.205 
30.912 
Behavior Cluster 
Group 
Treatment 
Interaction 
Intellectual and 
Group 
Treatment 
Interaction 
1,20 
1,20 
1,43 
School 
1,20 
1,20 
1,43 
Physical Appearance and 
Group 1,20 
Treatment 1,20 
Interaction 1,43 
Anxiety 
Group 
Treatment 
Interaction 
Popularity 
Group 
Treatment 
Interaction 
1,20 
1,20 
1,43 
1,20 
1,20 
1,43 
17.740 
1276.568 
2307.325 
Status Cluster 
132.361 
1298.205 
121.212 
Attributes 
578.619 
11. 364 
62.836 
8.358 
525.091 
9.187 
184.112 
349.455 
3.704 
Happiness and 
Group 
Treatment 
Interaction 
Satisfaction 
1,20 
1,20 
1,43 
Cluster 
70.020 
1171.114 
22.936 
* p < .05 
0.00 
15.77 
0.15 
0.45 
14.27 
0.41 
0.11 
11. 07 
0.27 
1. 33 
17.15 
1. 60 
3.91 
2.03 
1.15 
0.07 
6.15 
0.00 
1. 50 
5.43 
0.00 
0.91 
14.96 
0.29 
.9521 
.0068* 
.7037 
.5110 
.0012* 
.5282 
.7400 
.0034* 
.6121 
.2624 
.0005* 
.2203 
.0618 
.1696 
.2972 
.7937 
.0222* 
.9974 
.2356 
.0303* 
.9811 
.3513 
.0001* 
.5943 
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rable 13 
3elf-Reported Depression and Self-Esteem: T and 
J-values for Pretest and Posttest Group Means on 
~DI and Pier-Harris for UADD and AD-HD Groups 
Variable n 
CDI Total Scorea 
UADD 
ADHD 
10 
12 
Pre 
M 
13.7 
13.08 
Piers-Harris Total Scoreb 
UADD 
ADHD 
10 
12 
Behavior Clusterb 
UADD 
ADHD 
10 
12 
47.70 
51. 50 
41. 80 
44.75 
Post 
M 
5.1 
6.00 
59.40 
59.83 
54.40 
54.00 
2.80 
2.82 
-2.59 
-2.80 
-2.46 
-2.24 
Intellectual and School Status Clusterb 
UADD 
ADHD 
10 
12 
43.10 
49.92 
57.60 
57.75 
Physical Appearance and Attributesb 
UADD 
ADHD 
10 
12 
Anxiety Clusterb 
UADD 
ADHD 
10 
12 
48.90 
58.58 
48.80 
49.67 
Popularity Clusterb 
UADD 
ADHD 
10 
12 
41. 50 
45.67 
54.70 
59.58 
55.70 
56.58 
47.20 
51.25 
Happiness and Satisfaction Clusterb 
UADD 
ADHD 
* p < .05 
10 
12 
45.60 
49.58 
a CDI M = 9, SD= 4 
57.50 
58.58 
-3.36 
-2.45 
-1. 37 
-0.48 
-1.62 
-1. 89 
-1. 36 
-2.03 
-2.80 
-2.66 
.0208* 
.0168* 
.0291* 
.0173* 
.0363* 
.0466* 
.0084* 
.0325* 
.2037 
.6432 
.1403 
.0861 
.2055 
.0678 
.0207* 
.0220* 
b T-score > 70 indicates significant problem behavior 
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CDI score 
14 
12 
10 
8 
e 
UADD• ADHD• 
V:,:,==4 pre B post 
• p < .05 
Figure 1. Group mean pre and post scar.es for 
self-reported depression. 
Table 14 
Number of Responders versus Nonresponders to Stimulant 
Medication Based on CDI Scores for UADD and AD-HD 
Groups Using Fisher's Test for 2 X 2 
Responders 
(CDI < 14) 
Nonresponders 
(CDI > 14) 
* p < .05 
UADD 
<n = 5) 
5 
0 
a CDI M = 9, SD= 4 
ADHD 
(n = 6) 
6 
1 
58 
59 
after stimulant medication. The results support rejection 
of the null hypothesis that there would be no improvement 
in self-reported depression following a trial of stimulant 
medication. The results support acceptance of the null 
hypothesis that there would be no significant differences 
between the two groups in their response to stimulant 
medication on self-reported depression. 
Pretest and posttest Piers-Harris Total Score T-
scores and cluster scale T-scores were compared for UADD 
and AD-HD subjects by repeated measures two-way analyses of 
variance (see Table 12) and post hoc paired t-tests (see 
Table 13). There was not a significant group X group main 
effect between UADD and AD-HD groups for the pretest Total 
score or cluster scale scores. There were significant 
treatment main effects for both groups in Total Score 
T-scores and the Behavior, Intellectual and School Status, 
Popularity, and Happiness and Satisfaction cluster scores . 
Figures 2 through 5 demonstrate the changes in pretest and 
posttest mean scores on the Piers-Harris Total Score and 
cluster scores. No significant treatment X group 
interaction effects between UADD and AD-HD groups on 
stimulant medication were found on the Piers-Harris Total 
Scores or cluster scores. Results support rejection of 
the null hypothesis that there would be no differences 
between pretest and posttest scores for self-reported 
self-esteem for UADD or AD-HD groups. Results support 
acceptance of the null hypothesis that there would be no 
differences between UADD and AD-HD groups in their response 
to stimulant medication on self-reported self-esteem. 
Total T-score 65.----------- - ------------~ 
60 
55 
50 
45 
40 
35 
30 L-- -==== ~ 
UADD• ADHD• 
I > I pre - post 
• p < .05 
Figure 2. Mean pre and post scores for Piers-Harris 
Total Score . 
T-score 
6o r~~~~~~~~~~~~~~~~~~~~~~ 
UAOD• ADHD• 
I I pre - post 
* p < .05 
Figure 3. Mean pre and post scores for Piers-Harris 
Behavior Cluster. 
60 
T-score 
65r-~~~~~~~~~~~~~~~~~~~~~~ 
60 
55 
50 
45 
40 35Lll lmL_ .. . 
UADD• ADHD• 
11 pre - post 
*P < .05 
Figure 4. Mean pre and post scores for Piers-Harris 
Intellectual Cluster. 
T- scores 
65 r--~~~~~~~~~~~~~~~~~~~~~-
60 
55 
50 
45 
• p < .05 
UADD• ADHD• 
E2J pre B post 
Figure 5 . Mean pre and post scores for Piers-Harris 
Happiness Cluster. 
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Problem behavior. Repeated two-way analyses of 
variance and post hoc paired t-tests were computed to 
compare pretest and posttest mean Hyperactivity Index 
T-scores on the CPRS-R and TBRS for both UADD and AD-HD 
groups (see Table 15). There was not a significant group 
X group main effect (2 < .05) between UADD and AD- HD 
groups on the mean pretest CPRS-R Hyperactivity Index 
T-score, E (1,20) = 2.35. A significant treatment main 
effect between pretest and posttest scores was found on the 
CPRS-R, E (1,45) = 11.70, 2 < .003. There was significant 
improvement in the mean CPRS-R Hyperactivity Index T-score 
for the AD-HD group, t (12) = 2.92, 2 < .02, but not for 
the UADD group, t (11) = 1.86 (see Figure 6) . There was 
not a significant group X treatment interaction (2 < .05), 
E (1,43) = 0.65 between UADD and AD-HD subjects and 
stimulant medication on the CPRS-R group mean Hyperactivity 
Index T-scores. The results support rejection of the null 
hypothesis that there would be no differences between 
pretest and posttest parent ratings of 
i nattentive/hyperactive behavior for either UADD or AD-HD 
groups. Results support acceptance of the null hypothesis 
that there would be no significant differences between UADD 
and AD-HD groups in their response to stimulant medication 
on parent ratings of inattentive/hyperactive behavior. 
A significant group X group main effect was found in 
the TBRS pretest mean Hyperactivity Index T-scores between 
the UADD and AD-HD groups, E (1,20) = 20.39, 2 < .0001. 
AD-HD subjects were rated significantly higher (N 74.1) 
than UADD (M = 63.75) before treatment on the TBRS. There 
Table 15 
Parent and Teacher Ratings of Problem Behavior: 
F-Ratios. T-values and p-values for Pretest and 
Posttest Group Mean T-scores on the CPRS-R and TBRS 
for UADD and AD-HD Groups 
Scale 
CPRS-R 
Group 
Treatment 
Interaction 
TBRS 
Group 
Treatment 
Interaction 
Scale !l 
CPRS-Ra 
UADD 11 
ADHD 12 
TBRsa 
UADD 10 
ADHD 10 
* 2 < .05 
REPEATED MEASURES ANOVA 
1,20 
1,20 
1,43 
1,20 
1,20 
1,43 
Pre 
M 
70.91 
80.58 
63.75 
74.10 
514.79 2.35 
1840.891 11. 70 
101. 746 0.65 
1794.315 20.39 
1584.000 32 . 59 
66.826 1. 37 
PAIRED T-TEST 
Post 
M 
61. 36 
65.08 
49.50 
64.80 
1. 86 
2.92 
6.13 
2.51 
.1404 
.0026* 
.4303 
.0002* 
. 0000* 
. 2548 
.0923 
.0139* 
.0001* 
.0331* 
a T-score > 70 indicates significant problem behavior 
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T-score 
100r-~~~~~~~~~~~~~~~~~~~--, 
80 
60 
40 
20 
UADD ADHD• 
CZJ pre m post 
*P < .05 
Figure 6. Mean pre and post scores for parent-rated 
attention problems on CPRS. 
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was also a significant treatment main effect found for both 
groups, E (1,20) = 32.59, 2 < . 0000. There was a 
significant change from pretest to posttest on the TBRS 
Hyperactivity Index for both the UADD group, t (12) = 6.13, 
2 < .0002, and the AD-HD group, t (10) = 2.51, 2 < . 04 
(see Figure 7). A significant group X treatment 
interaction between UADD and AD-HD groups and stimulant 
medication (2 < .05) was not found, E (1,43) = 1.37. AD-HD 
subjects' teachers perceived their children as exhibiting 
significantly more hyperactive behavior than UADD subjects 
prior to a trial of stimulant medication. There was 
significant improvement in teacher ratings of 
attention/hyperactive behavior for both UADD and AD-HD 
T-scores 
80 
70 
UAOO• AOHO• 
CIJ pre • post 
• p < .05 
Figure 7. Mean pre and post scores for teacher-rated 
attention problems on TBRS. 
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groups following a trial of stimulant medication. These 
results support rejection of the null hypothesis that there 
would be no difference between pretest and posttest scores. 
Results support the acceptance of the null hypothesis that 
there would be no significant differences between UADD and 
AD-HD groups in their response to medication on hyperactive 
problem behavior. 
Mean pretest and posttest subscale T-scores on the 
CBCL (parent and teacher forms) for UADD and AD-HD groups 
were compared using repeated measures two-way analyses of 
variance (see Table 16) and post hoc paired t-tests (see 
Table 17). Significant group X group main effects (Q<.05) 
Table 16 
Teacher Ratings of Problem Behavior: F-Ratios and 
p-values for Group Mean T-scores on CBCL for UADD 
and AD-HD Groups 
REPEATED MEASURES ANOVA 
Aggressive 
Group 1,19 407.154 6.89 .0167* 
Treatment 1,19 148.593 4.50 .0474* 
Interaction 1,41 31. 002 0.94 .3449 
Hyperactive 
Group 1,19 488.202 4.27 .0528 
Treatment 1,19 77.357 1. 02 .3251 
Interaction 1,41 10.87 0.14 .7092 
Inattention 
Group 1,17 150.332 5.79 .0278* 
Treatment 1,17 751.605 28.07 .0001* 
Interaction 1,37 6.639 0.25 .6249 
Social Withdrawl 
Group 1,19 11. 811 0.11 .7444 
Treatment 1,19 106.881 1. 92 .1821 
Interaction 1,41 2.716 0.05 .8276 
Anxiety 
Group 1,19 18.651 0.90 .3560 
Treatment 1,19 1.190 0.00 1.0000 
Interaction 1, 41 28.097 1. 48 .2382 
Self-Destructive 
Group 1,19 171. 54 7 6.48 .0197* 
Treatment 1,19 34.381 1. 55 .2279 
Interaction 1,41 3.841 0.17 .6817 
Unpopular 
Group 1,19 52.737 0.65 .4302 
Treatment 1,19 247.714 8.13 .0102* 
Interaction 1,41 4.383 0.14 .7087 
* p < .05 
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Table 17 
Teacher Ratings of Problem Behavior: T and p-values 
for Pretest and Posttest Group Mean T-scores on CBCL 
for UADD and AD-HD Groups 
Scale n 
Aggressivea 
UADD 12 
ADHD 9 
Hyperactivea 
UADD 12 
ADHD 9 
Inattentiona 
UADD 11 
ADHD 8 
Social Withdrawla 
UADD 12 
ADHD 9 
Anxietya 
UADD 12 
ADHD 9 
Unpopulara 
UADD 12 
ADHD 9 
* Q < . 05 
Pre 
!1 
62.33 
66.89 
62.42 
70.33 
65.00 
69.88 
63.33 
62.78 
57.58 
57.89 
63.17 
64.78 
PAIRED T-TEST 
Post 
!1 
57.08 
65.11 
60.58 
66.44 
56.82 
60.00 
60.58 
59.00 
59.00 
56.00 
57.75 
60.67 
2.47 
0.59 
0.42 
1. 64 
4.42 
3.20 
0.80 
1. 34 
-0.68 
1. 30 
2.47 
1. 53 
.0313* 
.5726 
.6802 
.1397 
.0013* 
.0152* 
.4381 
.2183 
.5091 
.2282 
.0311* 
.1656 
a T-score > 70 indicates significant problem behavior 
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between UADD and AD-HD groups were revealed for the 
Aggressive (E = 6.89) and Inattention (E = 5.79) scales on 
the CBCL (teacher form). AD-HD children (M = 66.89) were 
rated significantly higher than UADD subjects (M = 62.33) 
on the Aggressive scale. AD-HD children (M = 69.88) were 
rated higher than UADD children (M = 65.00) on the 
Inattentive scale. Significant treatment main effects were 
found on the Unpopular (E = 8.13, 2 < .02), Inattention (E 
= 28.07, 2 < .0001), and Aggressive (E = 4.50, 2 < . 05) 
subscales. Post hoc t-tests revealed significant 
improvement on the Unpopular (i {11} = 2.47, 2 < .05), 
Inattention (i {10} = 4.43, 2 < .05), and Aggressive (i 
{11} = 2 . 47, 2 < .05) scales for the UADD group, while 
significant improvement was only found on the Inattention 
scale, i (7) = 3.20,-12. < .05, for the AD- HD group (see 
Figures 8 through 10). No significant group X treatment 
interaction effects between UADD and AD-HD subjects and 
stimulant medication were found. These results support 
rejection of the null hypothesis. 
A significant group X group main effect (2 < .05) was 
revealed between the UADD and AD-HD groups on the pretest 
Hyperactive subscale of the CBCL (parent form), E (1,21), 
2 < .03 (see Table 18). AD-HD subjects (M = 77.75) were 
rated significantly higher by parents than UADD subjects (M 
= 70.27). No other significant group X group main effects 
between UADD and AD-HD groups were found. Significant 
treatment main effects from before treatment to after 
treatment were found on the Depressive, Aggressive, 
Hyperactive, and Delinquent subscales (see Table 19). 
UADD• ADHD 
EJ pre - pos t 
• p < .05 
Figure 8. Mean pre and post scores for teacher - rated 
unpopular i ty on CBCL. 
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67 
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63 
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59 
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T- acore 
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UADD• ADHD 
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• p < .05 
Figure 9. Mean pre and post scores on teacher-rated 
aggression on CBCL. 
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T-score 
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70 
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• p < .05 
Figure 10. Mean pre and post scores for teacher-rated 
inattention on CBCL. 
70 
Significant improvement was revealed from pretest to 
posttest on the Anxious (t = 2.40}, Depressive (t 4.00), 
Uncommunicative (t = 2.40), Hyperactive (t = 2.50), and 
Aggressive (t = 3.27) scales for the UADD group (see 
Figures 11 through 16). Significant improvement was found 
on the Aggressive (t = 2.2) and Hyperactive (t = 2.88) 
scales for the AD-HD group. A significant group X 
treatment interaction was revealed on the Uncommunicative 
scale, ~ (1,33) = 4.80, between UADD and AD-HD subjects 
and response to stimulant medication (See Figure 15 and 
16). These results support rejection of the null 
hypothesis. 
Table 18 
Parent Ratings of Problem Behavior: F-Ratios and 
p-values for Pretest and Posttest Group Mean T-
Scores on CBCL for UADD and AD-HD Groups 
REPEATED MEASURES ANOVA 
Scale 
Anxious 
Group 1,14 14.860 0.20 .6633 
Treatment 1,14 69.031 3.23 .0937 
Interaction 1,31 76.612 3.59 .0790 
Social Withdrawl 
Group 1,20 56.447 0.37 .5483 
Treatment 1,20 27.841 0.89 .3577 
Interaction 1,43 3.400 0.11 .7456 
Depressive 
Group 1,19 19.281 0.18 .6737 
Treatment 1,19 408.595 8.90 .0076* 
Interaction 1,41 149.832 3.26 .0867 
Uncommunicative 
Group 1,15 150.010 0.86 .3672 
Treatment 1,15 16.941 0.40 .5345 
Interaction 1,33 201.309 4.80 .0446* 
Hyperactive 
Group 1,21 533.032 6.06 .0226* 
Treatment 1,21 887.043 14.50 .0001* 
Interaction 1,45 5.044 0.08 .7768 
Aggressive 
Group 1,21 1300.448 8.69 .0077* 
Treatment 1,21 801.392 14.75 .0010* 
Interaction 1,45 5.336 0.10 .7571 
* 2 < .05 
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Table 19 
Parent Ratings of Problem Behavior: T and p-values 
for Pretest and Posttest Group Mean T-scores on CBCL 
for UADD and AD-HD Groups 
PAIRED T-TEST 
Scale 
Anxious a 
UADD 
ADHD 
D. 
9 
7 
Pre 
M 
63.89 
62.14 
Social Withdrawla 
UADD 10 67.00 
ADHD 12 64.17 
Depressivea 
UADD 10 68.70 
ADHD 11 66.27 
Uncornrnunicativea 
UADD 9 64.67 
ADHD 8 64.00 
Hyperactivea 
UADD 11 70.27 
ADHD 12 77.75 
Aggressivea 
UADD 11 64.09 
ADHD 12 75.42 
* 12 < .05 
Post 
M 
58.22 
62.71 
64.80 
63.08 
58.50 
63.64 
58.67 
67.75 
62.18 
68.33 
56.45 
66.42 
2.53 .0354* 
-0.24 .8174 
0.73 .4845 
0.60 .5633 
3.96 .0033* 
0.82 .4332 
2 . 35 .0464* 
-1. 00 .3512 
2.50 .0316* 
2.88 .0151* 
3.27 .0085* 
2.52 .0284* 
a T-score > 70 indicates significant problem behavior 
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T-score 
69 
67 
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59 
57 
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• p < .05 
Figure 11. Mean pre and post scores for parent-rated 
depression on CBCL. 
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Figure 12. Mean pre and post scores for parent-rated 
anxiety on CBCL. 
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Figure 13. Mean pre and post scores for parent-rated 
uncommunicativeness on CBCL. 
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rigure 14. Mean pre and post scores for parent-rated 
lyperactivity on CBCL. 
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Figure 15. Mean pre and post scores for parent-rated 
aggression on CBCL. 
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Figure 16. Mean pre and post scores for parent-rated 
delinquency on CBCL. 
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overall, results support acceptance of the null 
hypothesis that there would be no differences in pretest 
and posttest scores of impulsivity following a trial of 
stimulant medication for either UADD or AD-HD groups. 
Results support rejection of the null hypothesis that there 
would be no differences between pretest and posttest 
measures of depression, self-esteem, or problem behavior 
following a trial of stimulant medication for either UADD 
or AD-HD groups. Significant improvement was found from 
pretreatment to posttreatment in self-reported depression 
and self-esteem and inattention for both groups. 
Significant improvement was found for the UADD group in 
uncommunicative, hyperactive, unpopular, and aggressive 
problem behavior while only improvement in hyperactive 
behavior for the AD-HD group. Results support acceptance 
of the null hypothesis that there would be no differences 
in the response to stimulant medication on measures of 
self-reported depression or self-esteem or impulsivity 
between UADD and AD-HD groups occurred. Results support 
rejection of the null hypothesis that there would be no 
differences between UADD and AD-HD groups in their response 
to stimulant medication on ratings of problem behavior. 
Table 20 presents a summary of all significant 
findings. 
Table 20 
Summary of Significant Findings 
1. AD-HD group> UADD group in parent-rated inattention/ 
hyperactive problem behavior 
2. AD-HD group> UADD group in parent-rated aggressive, 
hyperactive, and delinquent problem behavior 
3. Both AD-HD and UADD groups improved in self-reported 
depression following a trial of stimulant medication 
4. Both AD-HD and UADD groups improved in self-reported 
self-esteem 
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5. Improvement in parent-rated inattention/hyperactive 
problem behavior for AD-HD group but not for UADD group 
6. Improvement in teacher-rated inattention/hyperactive 
problem behavior for both AD-HD and UADD groups 
7. Improvement in teacher-rated aggressive and unpopular 
problem behavior for UADD group, but not for AD-HD 
group 
8. Improvement in teacher-rated inattentive problem 
behavior for both AD-HD and UADD groups 
9. Improvement in parent-rated anxious, depressive, 
uncommunicative, hyperactive, and aggressive problem 
behavior in UADD group 
10. Improvement in parent-rated hyperactive and aggressive 
problem behavior in AD-HD group 
CHAPTER V 
DISCUSSION 
lespite extensive research efforts, there remains 
consi{erable controversy and confusion concerning 
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child 1en with attention deficit disorders. Very few 
studiEs have been conducted that investigated the 
diffe 1ences between children with ADD/Hand children with 
ADD/WC. Of these studies, only a handful were prospective 
in na 1ure, utilized clinically-referred populations and 
were 1ree of significant methodological flaws. From the 
findi1gs of this limited research, there were indications 
that lDD/H and ADD/WO groups represented two distinct 
disorcers, rather than subtypes of the same disorder. To 
date, no studies have compared the more recent DSM-III-R 
categcries of AD-HD and UADD in terms of their clinical 
pictu1e or treatment. There continues to be a need for 
empir "cal investigations designed to clarify the etiology, 
diagncsis and assessment, and treatment of attention 
defic jt disorders in children. The present study was 
desigred to provide information that contributes to the 
underEtanding of attention deficit disorders in children by 
prospectively investigating clinically-referred children 
diagncsed as UADD or AD-HD. 
Objective 1 
'Ille first objective of this study was to identify the 
cognitive and affective characteristics of children with 
AD-HD and UADD and to determine the differences, if any, 
between these two groups. It was hypothesized that there 
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would be no significant differences (2 < .05) between 
these two groups on measures of intelligence, impulsivity, 
problem behavior, depression and self-esteem. 
Intellectual functioning. The results of this study 
support acceptance of the null hypothesis. No significant 
differences in the Full Scale IQ, Verbal IQ, or Performance 
IQ scores between UADD or AD-HD groups were revealed. 
Group mean Full Scale IQ, Verbal IQ and Performance IQ 
scores on the WISC-R were in the average range for both the 
UADD and AD-HD groups. There were also no significant 
differences on Kaufman's Verbal Comprehension, Perceptual 
Organization, or Freedom From Distractibility Index scores. 
The group mean scores for both the AD-HD and UADD groups 
were all in the average range. These results differ from 
previous research in certain respects. Four studies 
investigated the intellectual abilities of ADD/WO subjects 
(Carlson, Lahey, & Neeper, 1987; King & Young, 1982; Maurer 
& Stewart, 1980; & Neeper, 1985). In general, it was found 
that children with ADD/WO display average intellectual 
abilities. However, only three studies have compared the 
intellectual abilities of children with ADD/Hand ADD/WO. 
Carlson et al. (1987) found that ADD/H subjects obtained 
significantly lower Full Scale IQ and Verbal IQ scores than 
ADD/WO subjects. The results of the present study are 
inconsistent with the findings of Carlson et al. (1987). 
However, the subjects from their study were not 
clinic-referred and were classified into diagnostic groups 
on the basis of teacher ratings alone. The findings of 
this study are consistent with the findings of Lorys, Hynd, 
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and Lahey (1990) and Hynd, Lorys-Vernon, Semrud-Clikeman, 
Nieves, Huettner, and Lahey (in press) which found that 
both ADD/Hand ADD/WO groups possessed average intellectual 
abilities with no differences in verbal and nonverbal 
abilities. Further, there were no significant differences 
in the Freedom From Distractibility Index scores between 
the two groups. These results parallel the findings of 
Lorys et al. (1990), Bohline (1985) and Rubenstein and 
Brown (1984) who compared the Freedom From Distractibility 
Index scores of ADD/WO and ADD/H subjects and found no 
significant differences. 
Impulsivity. Results of the present study provide 
some evidence to reject the null hypothesis. It was 
hypothesized that no significant differences would be found 
between children with DADD and AD-HD on measures of 
impulsivity. No significant differences (2 < .05) between 
AD-HD and DADD subjects in impulsivity as indicated by the 
total number of errors on the MFFT was found. However, 
there was a difference that approached significance (2 < 
.10) in mean latency time between AD-HD and DADD subjects 
with AD-HD subjects exhibiting a smaller mean latency time 
than DADD subjects. These results suggest that children 
with DADD are less impulsive and able to inhibit their 
impulses better than children with AD-HD. These results 
parallel the findings in studies looking at children with 
ADD/WO. Findings from previous research on ADD/WO have 
questioned the presence of impulsivity symptoms in ADD/WO 
subjects (Edelbrock et al., 1984; Lahey et al., 1985; 
Maurer & Stewart, 1980; and Pelham et al., 1981). Lahey et 
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al. (1985) suggested that impulsivity is a correlate of 
excess motor activity rather than inattentiveness and that 
impulsivity should not be required for a diagnosis of 
ADD/WO. Interestingly, the degree or severity of 
impulsivity was not found to be clinically significant for 
either group (i.e., group mean score> 1 standard deviation 
below the mean), particularly the AD-HD group in this 
study, which could explain the lack of robustness in terms 
of differences in impulsivity between the AD-HD and UADD 
groups. However, the failure to find significant 
differences may also be related to the imprecision of the 
MFFT used to assess impulsivity. The psychometric 
properties of the MFFT are not particularly strong (see 
discussion in Methods section) and may not have been 
sufficiently sensitive. There are other instruments 
that have been recently developed utilizing computer 
technology to assess impulsiveness and have been proven to 
be more accurate and reliable than the MFFT such as 
computerized continuous performance tasks (e.g., Gordon, 
1979) . 
Depression, anxiety, and self-esteem. It was 
hypothesized that there would be no significant differences 
(Q < .05) between children with UADD and AD-HD in 
self-reported depression and self-esteem or behavior 
ratings of affective problem behavior. No significant 
difference was found between AD-HD and UADD groups in 
self-reported depression suggesting acceptance of the null 
hypothesis. The results are consistent with the findings 
of Lahey et al. (1984) comparing ADD/Hand ADD/WO subjects 
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in self-reported depressive symptomatology. Lahey et al. 
(1984) found that subjects in both ADD/Hand ADD/WO groups 
' reported more depression than controls, but found no 
differences between ADD/Hand ADD/WO groups in 
self-reported depression. No other studies have 
investigated the differences between ADD/WO and ADD/H 
groups to date. It is unclear how children with UADD and 
AD-HD compare to normal children in depressive 
symptomatology from the present study since no normal 
control group was utilized. However, comparing group means 
to the normative sample indicated that they did not 
experience significant depressive symptoms as groups. 
Results of parent and teacher ratings of affective problem 
behavior support acceptance of the null hypothesis. There 
were no differences between AD-HD and UADD subjects in 
parent or teacher ratings of depressive or anxious problem 
behavior. Both teacher and parent perceptions of 
depressive behavior were within the normal range (CBCL 
scaled T-score < 70). The results o f the present study are 
not consistent with the findings of Lahey et al. (1984) and 
Neeper (1985) who investigated the teacher ratings of 
affective problem behavior in children with ADD/Hand 
ADD/WO, but do parallel the findings of · Edelbrock and 
Achenbach (1984) . Neeper found that children with ADD/WO 
were judged as more anxious-depressed than controls by 
teachers. Lahey et al. (1984) found teacher to perceived 
children with ADD/WO as more anxious-withdrawn than 
controls. Edelbrock and Achenbach (1984) on the other 
hand, found that ADD/Hand ADD/WO groups did not differ 
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from each other or from controls on teacher ratings of 
anxiety. Uncommunicative behavior as rated by parents has 
been suggested to be related to depression in children 
(Achenbach & Edelbrock, 1983). No significant differences 
between children with UADD and AD-HD in uncommunicative 
behavior were found. 
In terms of self-esteem, the present study found no 
differences between the UADD and AD-HD groups in 
self-reported self-esteem. Both groups possessed 
self-perceptions within normal limits in terms of overall 
self-esteem, as well as their behavior, academic 
functioning, physical appearance, anxiety, and general 
level of happiness and satisfaction, suggesting acceptance 
of the null hypothesis. These results are inconsistent 
with the research with children with ADD/WO (Lahey et al ., 
1984) that found children with ADD/WO rated themselves as 
less happy and reported lower self-esteeem concerning their 
physical appearance and anxiety experienced than did 
controls (Lahey et al., 1984). However, the subjects for 
the Lahey study were not clinic-referred and were 
classified into diagnostic categories based solely on 
teacher ratings which may account for the differences in 
the results. 
Problem behavior. Several problem behavior areas were 
the focus of the present study. It was hypothesized that 
there would be no significant differences in 
inattention/hyperactivity, peer relations, or conduct 
problem behaviors. Results of the present study indicate 
some evidence to support rejection of the null hypothesis, 
while other evidence supports acceptance of the null 
hypothesis. 
84 
:n terms of attention/hyperactive problem behavior, 
there were no significant differences between children with 
UADD and ADHD in their teachers' perceptions of attention 
or hyperactive problem behavior. Interestingly, in 
looki ng at the groups' mean scores, neither group showed 
signi f icant clinical impairment (i.e., Mean Hyperactivity 
Index T-score > 70). AD-HD subjects were rated as more 
inattentive/hyperactive than UADD subjects by their 
paren t s. However, this may reflect the presence of more 
aggressive problem behaviors in children with AD-HD and not 
more ~nattentive/hyperactive behavior. It has been 
suggested that the Hyperactivity Index scale of the CPRS-R 
is mor e reflective of conduct problems than simply 
inattention/hyperactivity (Barkley , 1988). As will be 
discussed below, children with AD-HD were rated by parents 
as exhibiting more aggressive and delinquent problem 
behav:ors. Overall, there do not appear to be differences 
between the two groups in inattentive/hyperactive problem 
behav : ors, suggesting acceptance of the null hypothesis. 
In terms of peer relationships, this study found no 
signi:icant differences between UADD and AD-HD groups in 
socia withdrawl on teacher or parent ratings, supporting 
accep t ance of the null hypothesis. These results are 
inconsistent with previous literature investigating 
diffe r ences between children with ADD/Hand ADD/WO. Peer 
relat i onship problems have been described in children with 
ADD/H (e.g., Hynd et al., in press; Edelbrock et al., 1984; 
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King & Young, 1982; Lahey et al, 1984) and in children with 
ADD/WO (King & Young, 1982; Lahey et al., 1984). 
Particularly, differences have been found between ADD/H 
and ADD/WO in social withdrawl. Pelham et al. (1981) 
found that peers perceived girls with ADD/WO as more 
withdrawn than girls with ADD/H. Edelbrock et al. (1984) 
found that teacher ratings of boys with ADD/WO in terms of 
unpopularity were not significantly different from a group 
of control children, but did find that boys with ADD/WO 
were seen as significantly more socially withdrawn than 
boys with ADD/H. The results of the present study, 
indicating that children with UADD did not exhibit 
significant social withdrawl, are somewhat unexpected in 
comparison to the literature on ADD/WO and difficult to 
explain. The rather small sample size of the present study 
may account for the lack of significant differences in 
social withdrawl between AD-HD and UADD groups. It may 
also be possible that the UADD and ADD/WO diagnostic 
categories are not equivalent and that the presence or 
absence of social withdrawl is a differentiating factor. 
In terms of aggressive, delinquent, and conduct 
problem behaviors, this study found mixed results. There 
were no significant differences in teacher perceptions of 
aggressive or conduct problem behavior between the UADD and 
AD-HD groups. Further, teacher ratings of aggressive and 
conduct problems were not clinically significant for either 
the AD-HD or UADD groups. However, AD-HD subjects were 
perceived as exhibiting more aggressive, hyperactive, and 
delincuent problem behaviors than UADD subjects by their 
parents. These results suggest rejection of the null 
hypothesis. The higher incidence of conduct/aggressive 
problem behavior in AD-HD subjects compared to UADD 
subjects found in the present study corresponds 
consistently with the results of previous studies. 
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Children with ADD/Hare frequently characterized by 
aggression and or conduct disorders while children with 
ADD/WO are not (e.g., Hynd et al., in press; Edelbrock et 
al., 1984; King & Young, 1982; Lahey et al., 1984). 
Further, only one study has found that children with ADD/WO 
had conduct problems (Maurer & Stewart, 1980). The results 
of the present study suggest that the behavior problems 
children with AD-HD and UADD are similar to those of ADD/H 
and ADD/WO in that children with UADD have an absence of 
conduct behavior problems similar to ADD/WO whereas 
children with AD-HD possess significant aggressive-conduct 
problem behaviors. 
Objective 2 
The second objective of this study was to determine 
the effects of stimulant medication on children diagnosed 
as UADD and AD-HD and determine if differences between the 
two groups on measures of impulsivity, problem behavior, 
and self-reported depression and self-esteem existed. 
Twelve children diagnosed as UADD and 12 children diagnosed 
as AD-HD were compared before and after a trial of 
methylphenidate. There were two null hypotheses. First, 
it was hypothesized that there would be no significant 
differences in the pretest and posttest scores before and 
after a trial of stimulant medication for either UADD or 
AD-HD groups. The second hypothesis was that there would 
be no differences between children with UADD and AD-HD in 
their response to stimulant medication. 
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Impulsivity. Results of this study support acceptance 
of the null hypothesis in terms of impulsivity. There were 
no significant differences between UADD and AD-HD subjects 
who were included in the treatment study on measures of 
impulsivity before or after a trial of stimulant 
medication. Further, results indicated no significant 
changes in mean latency time or total errors on the MFFT 
from before treatment to after treatment for either group. 
Neither was there any significant differences between the 
two groups in response to stimulant medication on measures 
of impulsivity. These results were rather unexpected given 
that stimulants have been demonstrated to improve impulsive 
behavior (Barkley, 1988). It may be that since impulsivity 
was not found to be a significant problem behavior for 
subjects in either group in this study, any changes that 
were to be found would not be great enough to produce 
statistically significant results. The lack of significant 
differences in impulsive behavior between UADD and AD-HD 
groups are consistent with the findings of Lahey et al. 
(1984) which were previously discussed, and suggests that 
impulsivity may not be as critical a problem behavior in 
individuals with attention deficit disorders as believed. 
Further, it might be that the MFFT is an inadequate measure 
of impulsivity. 
Depression, anxiety, and self-esteem. It was 
hypothesized that there would be no significant differences 
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(~ < .05) in self-reported depression or self-esteem or 
behavior ratings of affective problem behavior as a result 
of a trial with stimulant medication for either UADD or 
AD-HD subjects. Results of the present study support 
rejection of the null hypothesis. Significant changes in 
self-reported depression from before treatment to after 
treatment was found for both groups. While it is found 
that adults will report significantly improved mood when 
taking stimulant medication, children rarely report 
elevations in mood as a result of stimulant medication 
(Barkley, 1981). In fact, several studies in the 
literature report that children experience negative 
emotions as a results of stimulant medication (e.g., 
Barkley, 1981). There was no significant difference 
between AD-HD and UADD groups in their response to 
stimulant medication on measures of self-reported 
depression, supporting acceptance of the null hypothesis 
that there would be no differences between children with 
AD-HD and UADD in their response to stimulant medication on 
measures of self-reported depression. There are no 
previous studies that have investigated differences between 
ADD/Hand ADD/WO groups in their response to stimulant 
medication. 
Interestingly, parents judged children with UADD as 
exhibiting significantly less depressive problem behavior 
after a trial of stimulant medication while there was not 
any significant change in parents' perceptions of 
depressive symptoms in children with AD-HD following a 
trial of stimulant medication. Also, parents rated children 
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with UADD as exhibiting significantly less uncommunicative 
behavior after a trial of stimulant medication. There was 
no significant change in parents' perceptions of 
uncommunicative behavior exhibited in children diagnosed as 
AD-HD after a trial of stimulant medication. However, 
there was no significant difference between UADD and AD-HD 
groups in their response to stimulant medication based on 
parent ratings of depressive and uncommunicative problem 
behavior observed. Only one study has been identified 
which reported improved mood as a result of stimulants in 
children identified as hyperactive (Rapaport, Buchsbaum, 
Zahn, Weingarten, Ludlow, & Mikkelsen, 1978). She looked 
at the effects of Dexedrine in children with hyperactivity 
children and found that they reported having feelings which 
they described as "funny" or "different". On the other 
hand, Barkley (1977a) noted in a review of stimulant 
medication effects that several studies have found negative 
emotional side effects as a result of stimulants. No 
previous studies have been conducted looking at differences 
between children diagnsosed as having ADD/Hand UADD in 
their response to stimulant medication based on affective 
functioning. 
It was also shown that stimulant medication was 
effective in improving both UADD and AD-HD subjects' 
self-perceptions, suggesting rejection of the null 
hypothesis. There was a significant improvement in 
children's overall self-esteem as well as their perceptions 
concerning their behavior, academic performance and 
potential, and feeling of happiness after a trial of 
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stimulant medication in comparison to their self-reported 
self-esteem prior to a trial of stimulant medication for 
both AD-HD and UADD groups. There were no significant 
differences between the two groups in self-reported 
self-esteem following stimulant medication, suggesting 
acceptance of the null hypothesis. Again, no other studies 
to date have been conducted looking at the differential 
effects of stimulant medication between children with ADD/H 
and ADD/WO on measures of self-esteem. 
Problem behavior. It was hypothesized that there 
would be no significant changes in problem behaviors on 
measures of attention/hyperactivity, peer relationships, or 
aggressive/conduct problems following a trial of stimulant 
medication or significant differences between UADD and 
AD-HD groups in their response to stimulant medication. 
Results of the present study support rejection of the null 
hypothesis. 
In terms of inattentive/hyperactive problem behaviors, 
Parents rated AD-HD subjects as significantly improved in 
hyperactive behavior following a trial of methylphenidate, 
while there was no significant changes in parents' 
perceptions of inattentive/hyperactive behavior in children 
with UADD following a trial of stimulant medication. There 
was significant improvement in teachers' ratings of 
attention/hyperactive behavior for both UADD and AD-HD 
groups following a trial of stimulant medication. Numerous 
studies have demonstrated decreased motor activity in 
children with hyperactivity as a result of stimulant 
medication (e.g., Barkley, 1977b). No previous research 
has been conducted looking at the differences between 
children with ADD/Hand ADD/WO in their response to 
stimulant medication in terms of hyperactive/inattentive 
behavior. 
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In terms of social withdrawl, there were no 
significant changes in teacher or parent ratings of social 
withdrawl as a result of a trial of stimulant medication in 
either the UADD or AD-HD group. Nor were there significant 
differences between AD-HD subjects and UADD subjects in 
their response to stimulant medication based on parent or 
teacher ratings of social withdrawl problem behavior. UADD 
subjects were perceived by their teachers as having 
improved peer relations after a trial of stimulant 
medication. There were no significant changes in teachers' 
perceptions of children with AD-HD in their peer 
relationships. These results support rejection of the null 
hypothesis. No significant difference was found between 
UADD and AD-HD in the teacher ratings of peer relationships 
from before treatment to after treatment. These results 
support acceptance of the null hypothesis. Cantwell (1990) 
has reported that the peer, parent and teacher interactions 
of children with hyperactivity improve as a result of 
stimulant medication. This was not found in the present 
study. The lack of significant improvement in peer 
relations following a trial of stimulant medication may be 
accounted for by the fact that poor interpersonal 
relationships were not identified to be a significant 
problem in the present study. No studies to date are 
available which have looked at the differential effects of 
stimulant medication on anxiety or peer relationships 
between ADD/Hor ADD/WO. 
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In terms of aggressive and conduct problem behaviors, 
AD-HD subjects were rated as significantly more aggressive 
by both parents and teachers prior to a trial of stimulant 
medication. There was significant improvement in parent 
ratings of aggressive behavior from before stimulant 
medication to after stimulant medication for both UADD and 
AD-HD groups. There was also significant improvement in 
teacher ratings of aggressive behavior from before 
stimulant medication to after stimulant medication for 
children with UADD but not for children with AD-HD But, 
there was no significant differences between the groups in 
their response to stimulant medication on teacher or parent 
ratings of aggressive behavior. These results suggest 
acceptance of the null hypothesis. Results are contrary to 
studies demonstrating reduced aggressive behavior and 
improved compliance to teacher and parent commands as a 
result of stimulants (Cantwell, 1990). 
Limitations 
A major difficulty encountered in conducting the 
present study was obtaining a sufficient number of 
subjects. Based on the number of clients seen in previous 
years in the Clinical Service Unit of the Developmental 
Center for Handicapped Persons at Utah State University, it 
was expected that there would be ample referrals from which 
to recruit potential subjects. Unfortunately, the number 
of referrals for possible attention deficit disorders to 
the Clinical Services Unit decreased dramatically at 
approximately the same time as the present study was 
initiated. 
plausible. 
Several explanations for the decrease are 
First, a media campaign within the state of 
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Utah was launched at approximately the same time which had 
a goal of raising the public's consciousness to the high 
prescription rate of methylphenidate in the state and to 
discourage parents from having their children evaluated 
and/or treated with stimulant medication. In fact, the 
clinical services staff encountered numerous families who 
refused to place their children on stimulant medication 
because of their concerns about the adverse effects of 
stimulant medication. Another plausible explanation for 
the decrease in referrals was the increase in other health 
professionals and agencies providing similar services 
within the area. Another possible reason was simply that 
there was a regression to the mean in the number of 
referrals for attention deficit disorder evaluations. It 
could be that the number of referrals in the year prior to 
the initiation of the present study from which an estimate 
of potential referrals was derived could have been at its 
peak, resulting in an exaggerated number of potential 
referrals expected. The statistical power of this study is 
a major weakeness of the study due to the low number of 
subjects available. 
Another limitation of the current study was the lack 
of a normal control group and non-ADD psychiatric control 
group with which to compare children diagnosed as UADD and 
children diagnosed as AD-HD so that more conclusive 
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statements could be made concerning the incidence or 
presence of problem behaviors within the experimental 
populations relative to normal and non-ADD psychiatric 
populations. Further, such control groups would have 
helped strengthen the conclusions drawn concerning the 
efficacy of stimulant medication with AD-HD and UADD 
groups. However, this would have been quite difficult to 
achieve, since it would have been very unlikely that 
parents of normal children would be willing to allow their 
children to participate in a drug efficacy study. A 
possible means with which to deal with this limitation in 
future studies is to utilize a double-blind treatment 
control group cross-over design in which the two 
experimental groups would be randomly assigned to both the 
stimulant medication and a placebo condition at different 
times to explore the effectiveness of the medication. 
Another limitation of the study concerned the methods 
implemented to identify the children as UADD or AD-HD. 
Independent diagnosis by three raters was used to 
accurately identify and classify subjects into two 
categories. current state of the art procedures utilitized 
include the use of structured interviews with parents and 
child. However, such procedures were not used due to the 
various clinical procedures among the various sites. Each 
of the sites from which subjects were recruited involved 
clinical populations and utilized unstructured clinical 
interviews rather than structured interviews. None of the 
sites were willing or able to change their practices to 
include the use of a structured interview. 
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Another potential limitation of the present study was 
the use of the MFFT as discussed above. The MFFT has been 
used extensively in the research as a measure of 
impulsivity, but lacks the precision of other instruments 
more recently developed. Future research should utilize 
more objective, precise measures of cognitive functions 
such as computerized performance tasks. 
Conclusions 
The purpose of the present study was to determine the 
cognitive and affective characteristics and the effects of 
stimulant medication on children identified as having UADD 
and AD-HD in order to gain a better understanding of the 
clinical pictures of the two disorders and their treatment. 
Intellectual functioning. It is concluded that there 
are no significant differences in the intellectual 
abilities of children diagnosed with AD-HD and UADD. Both 
children with AD-HD and UADD demonstrated intellectual 
functioning in the average range in terms of verbal, 
performance, and overall intellectual abilities. Further, 
there do not appear to be differences between the two 
groups in attention/concentration abilities. It is 
suggested that measures of intellectual functioning do not 
differentiate UADD and AD-HD. 
Impulsivity. It is unclear whether there are 
significant differences in impulsivity between AD-HD and 
UADD. There were some indications that children with AD-HD 
may have more difficulty in inhibiting their impulses than 
children with UADD similar to the findings of previous 
studies on ADD/WO that questioned the presence of 
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impulsivity in these children. Also, it is unclear whether 
stimulant medication produces any beneficial effect on 
impulsivity (i.e., reduction in impulsivity) in either 
children with UADD or AD-HD. Further research is needed in 
this area utilizing more sensitive measures. 
Depression, anxiety, and self-esteem. There appear to 
be no differences in affective characteristics between 
children with UADD and AD-HD. No differences were found 
between the two groups in self-reported depression or 
self-esteem or ratings of affective problem behavior. 
Further, it is unclear whether children with UADD and/or 
AD-HD experience more or less the same degree of depression 
as normal, however, there are indications that they do not 
exhibit depressive or anxious problem behavior or low 
self-esteem to a clinically significant degree as a group. 
This is quite different than what was expected given the 
literature on ADD/WO. It suggests that ADD/WO and UADD may 
not be comparable diagnostic categories. However, it may 
also be that what was considered affective problem behavior 
in the ADD/WO population was actually a sluggish tempo as 
described by Carlson (1986). Stimulant medication appears 
to have a beneficial effect in reducing depressive symptoms 
in both UADD and AD-HD. Stimulant medication with 
children with AD-HD and UADD also appears to improve 
overall self-esteem as well as self-perceptions concerning 
their behavior, school functioning, physical appearance, 
anxiety experienced and overall happiness. stimulant 
medication does not appear to have any differential effect 
between children with UADD and AD-HD on their affective 
functioning. 
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Problem behavior. There appear to be significant 
differences in the peer relationships and problem behaviors 
exhibited between children with UADD and AD-HD. Children 
with AD-HD seem to exhibit significantly more externalizing 
behaviors such as inattentive/hyperactive, aggressive and 
delinquent problem behaviors than children with UADD. 
Additionally, the problems with social withdrawl as found 
in ADD/WO was not found in the UADD population suggesting 
that the two sets of children are not comparable. 
Stimulant medication appears to have a benefical response 
in reducing the hyperactive problem behavior in children 
with AD-HD. Also, stimulant medication appears to have a 
beneficial response in improving the peer relations and 
reducing aggressive problem behavior in children with UADD 
but not in children with AD-HD. 
These results suggest that the clinical pictures of 
AD-HD and UADD categories reflect two distinct disorders, 
AD-HD, representing a disorder which has primary 
difficulties in inattention and possibly impulsivity and 
associated externalizing problem behaviors such as 
aggression and delinquency, and UADD, primarily involving 
deficits in attention. UADD does not seem to encompass 
internalizing affective problem behaviors such as 
depression, low self-esteem or anxiety such as found in 
ADD/WO and are not likely representing the same disorder. 
The findings also suggest that the treatment needs of 
the two disorders AD-HD and UADD differ because of the 
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additional associated problem behaviors of aggressiveness, 
poor peer relationships, and conduct problems of the AD-HD 
category. The findings of the present study suggest that 
stimulant medication is indicated as part of a 
comprehensive treatment plan for treating the 
inattention/hyperactive problem behavior of children with 
AD-HD, particularly, it there is the presence of depressive 
symptomatology or low self-esteem. Further, stimulant 
medication appears to be indicated for children with UADD 
who present with poor peer relationships or aggressive 
behavior. 
Stimulant medication appears to be insufficient as the 
sole intervention in the treatment of AD-HD, particularly 
if children with AD-HD present with aggressive,peer 
relations, or conduct behavior problems. Children with 
AD-HD have been purported to have deficits in social skills 
which result in significant problems in peer relationships 
and adversely affects their adjustment (Cantwell, 1990). 
Undoubtedly, this suggests a poor prognosis for such 
children. Results from this study suggest that it is 
crucial for the treatment plans for children with AD-HD 
include intervention strategies beyond stimulant medication 
that are designed to help foster positive interpersonal 
relationships and reduce conduct/aggressive problem 
behaviors. Social skills training and problem-solving 
skills training have been implemented to help children with 
attention-deficit disorders develop self-control with some 
success (e.g., Kendall, 1985; Braswell & Kendall, 1988). 
Additionally, programs for parent training and behavioral 
consultation within the schools have been developed and 
implemented to help children with attentional deficits 
learn the behavior repetoires so that they may meet the 
behavioral expectencies of the various settings in which 
they function (e.g., Barkley, 1981; Braswell, 1990). 
Recommendations for Future Reseach 
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Findings of the current study suggest children with 
AD-HD and ADD/Hare similar in their clinical pictures 
while the clinical pictures of UADD and ADD/WO are not and 
likely do not represent the same disorder. However, 
additional systematic studies comparing these two groups 
are needed to better clarify these categories. 
Findings suggest that children with AD-HD exhibit more 
aggressive/conduct problem behavior and poor peer 
relationships. Further, stimulants do not appear to be 
helpful in ameliorating these associated problem features. 
Such findings suggest a poorer prognosis for such children. 
Further research is needed to clarify the outcome of these 
children. Research is also needed to develop and implement 
alternative interventions such as social skills training 
and parent training in order to better meet the needs of 
AD-HD children. Such studies should be prospective, 
utilizing clinically-referred populations and double-blind 
treatment control group cross-over designs. 
The results of the present study suggest that 
stimulants may be effective in treating the problematic 
affective symptoms in attention-deficit disordered 
children. Research is needed that better clarifies the 
potential efficacy of stimulants in improving the mood of 
attention-deficit disordered children. 
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Research has been initiated in order to investigate 
the neurocognitive correlates that may differentiate ADD/H 
and ADD/WO (Hynd et al., in press; Lorys, et al., 1990). 
This area of research may be quite promising in clarifying 
the possible etiology of attentional deficits. Research 
investigating the neuropsychological correlates 
differentiating AD-HD and UADD may be illuminating in 
distinguishing between these disorders. 
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APPENDICES 
Appendix A 
Informed Consent Forms 
CONSENT FOR PARTICIPATION IN ATTENTION 
DEFICIT DISORDER SlUDY 
i13 
We are conducting a research study designed to help in the azsessment of two 
types of attention deficit disorders and to study stimulant medication 
effects for each type. Each child included in the study has already had a 
diagnosis of Attention-Deficit Hyperactivity Disorder or Undifferentiated 
Attention-Deficit Disorder, and the decision has been made to institute 
stimulant medication as part of the treatment program for your child. 
We are requesting your permission to use the data obtained during the 
evaluation and treatment of your child in order to obtain more information 
about children with Attentfon-Deffcit Disorder as a whole. 
The risks of participating in this study are minimal. Participation is 
strictly voluntary, and you or your child may withdraw at any time without 
affecting your child's treatment program. 
All records and information on your child will be kept fn strict confidence 
with records kept in a locked area. No fdentiffcatfon of your child will be 
made fn any written or published reports of the study and you may request 
and receive the results of the study when completed. 
Signature Date 
Relat1onsh1p to ch1ld 
W1tness 
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Information Sheet on Stimulant Medication 
Your child has been prescribed one of the stimulant medicines used to 
treat attention deficit disorder. These include Rftalfn (methylphenidate), 
Dexedrine, Desoxyn, and Cylert. The following summarizes side effects and 
other important information. 
Short Tenn Side Effects: Most conmen are: appetite suppression, insomnia, 
irr1tability, we1ght loss, and occasionally headaches and abdominal pain. 
These are usually dose related and temporary. Nervous tics are also seen 
occasionally and usually stop when medication is discontinued. Rarely, a 
serious disorder called Tourette syndrome-can be precipitated. This 
disorder involves irreversible, multiple tics and compulsive vocalizations. 
Because of the concern of developing Tourettte syndrome, ff a child taking 
stimulant medication develops tics. hfs/her physician should be contacted, 
and medication dfscontinued. 
All of these medications can produce signs of psychosis at high doses. 
Cylert uncommonly can cause liver abnormalfties. and for this reason 
periodic blood tests are reconmended when Cylert is prescribed. 
Long Term Side Effects: Potential long term side effects include height and 
we1gnt suppress1on and cardiovascular effects such as increased blood 
pressure and heart rate. The risk for all of these appears quite low. 
Because improvements are often quite dramatic. there is a potential for 
psychologic dependence. Emphasis should be made that medication is an 
adjunct to treatment and crediting a child's major successes to the 
stimulant medication should be avoided. Concern fs often raised about 
potential physical dependence or future drug abuse. Evidence suggests that 
this is very unlikely. 
Prescribing Information: With the exception of Cylert. the prescribing of 
all of these med1cat1ons is tightly controlled by the Federal Drug 
Administration (FDA). Only a one month supply of medfcation can be 
prescribed at one time. Prescriptions cannot be called in over the phone 
and prescriptions are not refillable. We request that you give us one week 
notice when a new prescription is needed so that there is no delay in you 
receiving the prescription. Prescriptions need to be filled within 24 hours 
of the date of the prescriptfon. 
If there are any questions regarding side effects or medication 
problems please contact either Louise Warren. R.N. or Dennis Odell, M.D. at 
750-2750. 
Appendix B 
Utah state University Human Subjects Review Board 
UT AH ST ATE UN IVERS I TY , LOGAN, UT AH 8 4 3 2 Z · 4 5 0 
OFFICE OF TlfE Ya PRESIOEHT 
FOR RESEARCH 
T-IIIOIJ 7S0-11ao 
MEMORANDUM 
TO: Or. Sebastian Striefel 
Dr. Phyllis Cole 
Richard Alan Campbell 
FROM: Sydney Peterson~ 
DATE: April 21, 1988 
SUBJEC;: Proposal Entitled, "Attention-deficit Hyperactivity 
Disorder and Undifferentiated Attention-deficit 
Disorder: Differences in Cognitive and Affective 
Characteristics and Response to Stimulant Medication" 
The above referenced proposal . has been reviewed and 
approved by the Institutional Review Board. 
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Appendix C 
University of Texas Southwestern Medical Center 
at Dallas Institutional Review Board 
11fE UNIVERSl'IYOF TEXAS 
Southwestern Medical cenrer 
ATDM.I..AS 
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lnstitutioaal Rmrw 8-d 
January 9, 1990 
SoadMm1I Medicll Sci,:,oi 
SoadMm11<JnmeSci,:,oi 
afBicmdi::al Scicaca 
~AUixltbldlScim;aSci,:,ol 
Mark Swanson, M.O. 
Department of Pediatrics 
RE: IRB FILE I 0190 03200 
Attention-Deficit Hyperactivity Disorder and 
Undifferentiated Attention-Deficit Disorder 
Dear Dr. Swanso~: 
On January 9, 1990, the Institutional Review Board considered the 
above-referenced study and approved the protocol and consent form 
as enclosed. Please use this approved consent form and destroy 
all other drafts or undated copies. The annual review of this 
study is scheduled for January 1991. 
University and Federal regulations require that written consent 
be obtained from all human subjects in your studies. The consent 
form should be kept on file for a period of three years past 
completion of the study. A copy of the consent form should be 
given to each participant fn your study. Also, the University 
attorneys have asked us to remind investigators to yut a copy of 
the consent form in the sub ect's medical record. nvestigators 
sou eep t e or,g,na , execute copy o t e consent form and 
file it with their records of the protocol. 
The HHS regulations require you to submit annual and terminal 
progress reports to our Institutional Review Board and to receive 
continuing review of your activity annually by this Board. You 
are also required to report to this Board any death or serious 
reactions resulting from your study. Failure to submit the above 
reports may result in severe sanctions being placed on the 
Southwestern Medical Center. Furthermore, if you require a 
modification to this protocol contact me in order that 
appropriate review and approval can be made prior to implementing 
the change. 
5323 llarry Hines Boulevard. BS·I Dallas. Tc:xu 75235-9016 214/688-3060 
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You are reminded that all grant applications and any solicitation 
of funds must be processed through the Office of Grants 
Management. Funds received as a result of an application having 
been submitted directly to a granting agency by a faculty member 
will not be accepted by the institution. If you have any 
questions related to t~is protocol or to the Institutional Review 
Board please contact me at extension 82258 or Romelle Hase at 
extension 83060. 
Sincerely, 
a~U,L~ 
Perrie M. Adams, Ph.D. 
Associate Dean for Research 
Chairman 
Institutional Review Board 
PMA/rh 
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Attention-Oeffci t Hyp~racti _vi ty Disorder and Undi fferent14ted Attenti on-Oefii:i t ·· 01 sorder: 
Differences in Cognitive and Affective Characteristics and Respo~se to Stimulant Medication 
,\!::tift GHHF Special Educatio~,i_t_er __ _ 
I ltJT"ee to use procedures wftll respect to S1fquardfn9 11- salajects f-lftd tn t1111 ,.._rdl tllat Cllllfol'III to tile IITllSCll 
policy • ..., OIIHS and f1lA "9ul1t1ons. uaot WIMft necusary co elflnaau apparent 1 .. 1ata ltaurd to tile 11- subject. if 
sfgn1f1cant cllu19es 1n tlle 1nwest19at1v. Pnicedures 111YOlwf119 ,,_ s!Mljectl a,. callN for dllr1119 tile rneardl p"°""'" 
conl"l!d by tll1s aopl1cat1on, 1 shall Sffi PMOI" 1ppnr,al for Suds cbUcJn f1"1119 tN Illltftlltfoul Rftiew loanl (IRII, Ud I 
slla 11 191"'ff to follow tlle adw1a of tlla lRI. . I farther a.,.a to report 1 .. 1atel1 to ta. IRI UJ vauttctpaced 
11cattons or waaiw.rd 1nddenU vjtb nspect to h- s!Mljecu. . 
1. Swanson 
1gn1tura 
904-2217 
Campbell 
nty lO 
19n1ture 
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If act1'1ty director 1s otller tllan faculty,,,_ faculty spoaon . _____________________ --1 
I undtntand ttlU respons1b111ty for 111essin9 tlla q ... llty of rnurdl mst be sbantl by botll tlle cSa,a~ and the IR!. J 
11qn1turt u Otoartmtnt Cha1,.,..n ctrt1f1es tllat tlla pnn,osad nsun:11 has bffft ....,;_ for tile Dl"DOel" use of h...n slllljecu. 
This rn,ew encaa,passed eipenllll!nul des1gn, sctent1f1c •1"1t llld accuracy of the Pl'IIPOIN nsurdl. 
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1~crtci1 OAT( 
(EXT IRS PEVIE'.I OAT(. 
- ..,: ,; , • . ·. :. ~ .)rr.1 ~ 2 
!£Jc~ Bo OAY WV£ SUNt 
IR! NIIIIER. ______________ -i 
ACTlOft 110. ______________ _. 
CATECORT OF REYIEll, __________ _ 
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USE Of' 1MW1 SUBJfCTS CHECXL I ST 
The purpose of this check I 1st 11 to Indicate those asi,acts of your appl !cation which require particular 
consideration to assure protection of human research subjects. Please C01111let1 the cnecktlst and return It 
111th your appl lcatlon. Using the outline provtded, atucn I suaary of your project 1114 Include the consent 
fora tnat you Intend to use. 
CHECK OFF RESPONSE AND COIIPLETE THE BUHJCS FOR EACH Of' THE fDUOIING l!HICH. JN YDUll OPINION, BEST DESCRIBES THE 
RESEARCH. 
1. RISK CATEGORY: No Risk -- 11101111 Risk -X-- llon T1lan lllnlaal Rlllc _ --
2. BENEFIT CATEGORY: Benefit to Subjects: Yes :·x or Ho Benefit to Others: \'II _x _ or Ho --
3 • . REQUESTED CATEGORY Of IRB. REVIEI: Ex1111t Exi,edlted ~ Raoular -- Eaergency _ ._ 
4. Does this research lnvolvi · the use-of drugs and/or dewlces? \'n X or Ho 
It eHrgency revle. Is requested. e~laln In a cover letter tha nitlil'l' of the eHrgency. 
5. condition or disease to Ile stUdled: 
6. SUBJECT POPUUTIOH: INDIC>.TE WHETHER THE fOUOIING ARE INVOLVED: 
a. -- NORIIAL SUBJECTS (non-i)atlent VOiunteers) 
ll. _x_ IIINORS (less than age 18) 
c. f'ETUSES: NONVIABLE VIABLE 
d. PREGNANT SUBJECTS 
e . PRISONERS 
f • IIENULLY RETARD ED 
g. MENTALLY IIIPAIRED 
h. __ AGED (over 65) 
I • X STIJDENTS 
J. IIINORITIES - Spec I fy 
k. INPATIENTS - U 8lUllrl11ntal sUbjects 
1. - 11 control sUbjects 
•. _x_ OUTPATIENTS - II exoerl1antal SUbjects 
n • ..L- - •• control SUtljects 
o. -- HOH-ENGLISH SPEAKING SUBJECTS - Native languages 
FOR EACH YES MENTIONED ABOVE IHClUOE JUSTIFICATION FOR THE USE Of' THIS SUBJECT (tlV of t he croJect summary). 
7. AOOITIOHAL IHfORIIATIOH: 
a. Sax of subj ects: llale __ female Both ...i.._ 
b. Age range : _ _..;8_-_1_6 _ _____ _ 
c. Estimated nt111Der of participants Involved: EX1lerl11ntal Subjects~ COntrol SubJects ~ 
d. Est tmated durat Ion of study : __ s_m_o_n_t_h_s ____________________ _ 
e . ouratlon of eacn subJect 's participation: _3._..m . p,..n t .. hs..._ _ ______________ _ 
f. WI 11 suoJects Ile paid to participate? Yes Na X 
g. State type and amount of incentive to be offered:-------------------
n. Wiii Incentive Ile ororated for subjects who withdraw fro• parttclcatton? Yes 
UT Soutn•estern OGM/ IRB for m •2 
~ev,seo C6/83 
NO 
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ADO I Tl OIIAl I IIFORIIATIOII ( contf nu.d) 
I. Eath•ted 8ddftfon11l coat• to aubJKta tllat..,. remlt f,- .-ctctpectom s _____ _ 
J. The -,nc, If .....,, c:lulr9ad for ., lmnctg.1ct-ldnlgfdfffce s · ..JS._. If aublKCa vfll be 
dlarved, state why sale doa not cwcftue• -1altzadon5ybje<;t:; would be taking medication 
even if not in studv. 
k. la tl'lere a confl let of fntemt be- tl'le fmNtfgacar Md die apanaor of tlle drut/device or 
procedUrn to be aaaf .. , e.11 •• __,..tp fn c:aapM'ff T• _ • ~ 
l. llfll placeooa be uaad7 T• 110 _X __ 
•· 11111 aublects be nndmlzed1 T• 
n. 11111 anvorw otller tl'lan tfle . fmntfgator<a) obtain fllfonled-7 TN_ .. -X-
lf •ns•, list: N- Tttla -------------
o. 11111 tl'le fmntfoatorcs> be directly frMllwd fn dl..-cfc and t,..._ procemrea for aubjecu7 
, .. ..L.. ... __ . 
p. o- tl'lta r .... rc11 proposal lrM1lw only tlla collactfon or acm, of atattng data, ~·· rac:orda, 
patl'lol~ical speci_. or di-etc speci-7 T• __ • ~ 
q. If tl'lo - to tl'le abaw qmatfon la "TES", are the•-- s,ubltcly awfllblo. or vlll tlle lnf-cfon 
be recorded by tl'lo i"""tf11acorc1) In aucll • -- tllat aublocta cm,not be tcllntfffed directly or"'"-" 
ldentitfoa llnkad to tho subjoccat T• lie • If ... dlfa acm,-,, -.,allfy u UMpt 
,... .. rc11 or for .,.. upaditad r.,,iov ~ -
a. US£ Of RADIOACTIVITY II IIIJWI SUI.IECTS: 
la ,,,.,., foni of radiation uud In tbfa aeudy? T• _ •....x-
a. If "TES", Indicate type uuds X•rr,a __ IMtapea - ,ti.-lcala _ 
b. An atudloa dmw !!1 l!i.1'!-- or !!1 ntti--" 
c. Are atudloa dmw for dl-tfc __ ~fc _ o,, apari-l __ puri,oaoat 
d. Nu tl'la lladlatfon safecy c:-ittN appn,val boon ncefwd fo,, tbla pn1Jact1 T• _ 
.. __ 
e. If •ns•, 11tw date of appn,w,ls -------------
Appn,nl of the Radiation SafetY c:-ittff ta ~red for all atudt .. IIMrivilll ndlacton. call t11e lladlacton 
~fetY office at oat-ion 42250 for further lnfo....tfon. 
Al I .!.!l !i.1'! studies .... , be approwd by the lladlatlon safotY Sactfon .,..tor to reviov by die Ill and tllo •Appl I cation 
for use of Radiation In ~- lHeardl• fora OH attKftad) .... , be caaplotad and aublrittad vida Ciiia application 
to tl'le IRI. 
9. CCOPEUTING FACILITIES: 
11111 soA>Jecta, equipnont, peraarnol, supplies be uud au 
Periland___ Aston___ CIIC~ VNC___ IIIC __ _ 
list facility, if otl'l~r· · ~ Developmental" Center for Handicapped Persons, Utah State University 
Hu protocol bffn approved by coopentincJ facil ltY7 Yes Logan, UT 84322 
. ~ .. 
For Parkland, attach copy of approval (attllCiled OCH fon, Al. Ill &""""'81 will not be finalized ..,ttl approval 
is received. 
UT Soutl'lwH trm OQ4/I RB Form #Z 
R•vlSl'd 07/89 
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10. USE or DRUGS AHO/OR DEVICES: COMPLETE THIS SECTION OHlY If QUESTION •• WAS ANSWERED "TES". If IT DOES 
NOT APPLY TO YOUR RESEARCH. DO HOT lllClUDE THIS PAGE WITH THE MATERIAL SU8111TTED TO THE IR8. 
a. 
Answer the question or check where aooroorlate If this activity lnYOIYH the UH of any drugs/devices 
regulated by the food and Drug Ad•lnlstratlon. Please ansnr the QUlltlona for~ drug/device used 
mether or not Its use Is considered to be lnvestlgatlonal. 
HAIIE OR DRUG/DEVICE: GENERIC •h 1 • "d • h d •J ·d TRADE _.Q..,f .... t .i,.._J..,.fn-..-------
. me. )1pnen1 11.e ) recmer, e CIBA 
CIIEIIICAL NAii£ Of IIANUF ACTURER. ------------
Is th Is an fDA aooroved drug? Yes -'L-
lf "HO", Indicate Phase Huaber, I 
Is this an FDA aooroved device? Yes 
No 
II 
Ho 
111 IY --• and IND 1 ------
If this Is an lnvestlgatlonal device, Is It considered to be a SIGNIFICANT RISI DEVICE or a 
NOHSIGHIFICAHT RISK ' DEVICE 7 llho Hdl this deter•lnatlon. e.g., Sponsor. fu.(, Prlncloal 
Investigator. etc.? -----------------------------------
If a waiver has been applied for, give expiration date: • 
-------
Give naa, of sponsor (person or coEpany, etc •• who hOlds IHD/IDE) ----------------
If this Is an FDA approved drug/device, Is It being used for a •11on~fDA" approved purpose? 
Yes Ho _i_ 
If ·yes·. state purpose: 
b. HAIIE OR DRUG/DEVICE: GENERIC ------------
TRADE ___________ _ 
CIIEIIICAl --------------
Is this an fDA approved drug? Yes 
If "HO", Indicate Phase Huaber. 
Is this an FDA approved da:vlce7 Yes 
If this Is an lnvestlgatlonal device, 
NOHSIGNlflCANT RISK DEVICE 7 
No 
II 
Ho 
HAii£ Of IIAHUf ACTURER ------------
111 IY --· and IND t ------
Is It considered to bl a SIGNIFICANT RISK DEVICE or a 
Who Hde this :11t1r•lnat1on, e.g., Sponsor. fDx:,,TTiiclpal 
Investigator, etc.? -----------------------------------
If a waiver hH been applied for, give exolratlon date: • --------
Give naa, of sponsor (person or coaoany, etc •• IIIIO hOlds IHD/IDC) ----------------
If this Is an fDA approved drug/device, Is It being used for a "Non-FDA" approved purpose? 
Yes__ Ho __ 
If "TES·. state purpose: 
c . NAME OR DRUG/DEVICE: GENERIC-------------
TRADE __________ _ 
CHEMICAL-------------- NAME Of IIAIIUf ACTURER -------------
Is this an fDA aoproved drug? Yes Ho 
If "HO". Indicate Phase Huaber. II 111 IV--· and IND 1 ------
Is this an fDA approved device? Yes Ho 
If this Is an lnvestlgatlonal device . Is It considered to be a SIGNIFICANT RISK DEVICE or a 
NOHSIGHIFICAHT RISK DEVICE ----' Who made this deter•lnatlon, e.g., Soonsor. fur.l'rTriclpal 
Invest I gator. etc. 7 ---------------------------------· 
If a nlver has been IPPI led for, give expiration date: 
Give name of sponsor (person or coap~ny. etc., who holds t::D/IOE) 
11 th Is Is an fOA a po roved drug/device. is It be tng used for a ·uon-fDA • approved ourpose7 
Yes 110 
If ·vrs·. state ouroose: 
~ state~ent thJt tile zoonsor Jszures tnH clinlc31 stl!dies In 1'u~!ns will r.ot t:e Initiated prior to :;o dJys 
aiter :ne dJtc ot rcce,ot of tne notice ty !~~ ;c::i 3n:I Crl!'1 :.=~•n1str!tlcn (fD~l. Jnd thJt he will continue to 
••tnnotd or restrict ctonlcal stc:i,cs ,t reo~~s:!:1 to CJ s,'cy t~.e fO~ prior to t~e exptrJtlon of sucn JO cJys . 
UT Soutn•estern OGM/IRo fora ,2 
Rev,sea 05/88 
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PROJFr.T SUMMARY 
I. Purpose: The intent of the pre-sent study is to examine the 
characteristics and treatment of children with Attention-
De,fici t Hyperactivity Dlsorder CADHD) and Undi f fere-nti ... ted 
Attc-ntion-deficit Hyperactivity Disorder CUADD) in order to 
bc-tte,r clarify the clinical pictures of the two disorders 
and their treatment. Speci .f~cally, the .ob_j.ctives of the 
study are:_ a) to identify differences ·, · .·i ·f any, between 
children '-:diagnosed as ADHD and .UADD ·on measures of 
cognition and affe.ct, and b)·to determine differences, if 
any, between ADHD and UADD childre-n in their response to 
stimulant . medication. · · · 
II. Bacl:ground: TI1ere is currently. a lack of research 
regarding the distinction between .. the DSM-III-R categories 
of ADHD and UADD... Research is ,needed clari tying th& 
differences in the cognitive- and aff.ctive characteristics 
of .. these ,:at egor ie-s. Further, .. ."r~searr.:h · i .s also nEo-,;.-ded to 
deterrnine appropriate :·tre&tment -ir1terventions for ·uADD. 
The-re are current! y no stlidies concerning the tre-atment of 
UADD. . . . . . . 
III. Concise Summary of ProjKt: ,SLibjects .-will be children ages 
8 .to 16 diagnosed as ..-ither Att"e-nti _cn'4ieficit ·Hyperactivity 
Disorder or Undifferentiated ~f'tt _e-ntlon-_defic:it. : Disorder 
according to th& Diagnosti~ <iit.nd · .... statistical -Manual . of 
Mental Disorders-Third Edition-Re-vised.. 8roups will be 
compared on a battery. ot · ccg·rt1t1 .Ve--.:·tnd ·at:tective · _measures 
prior to treatn,ent . Both groups··wfli° then be administered 
a trial of stimulant medication (Ritalin) for three months. 
Groups will be a&&ets&ed- · followi.ng·niedication trial 
and compared on a battery · of ·.-cognitive, and affective 
measures to ass£-55 :· .. treatment : •ff .~ts. 
IV, Criteria ~for I11dµsic;,nS:o.0_4't:JJro.!?i ~As .stated : __ above, 
subjects will be children diagnosed as either ADHD or UADD 
according to the Diagnostic and ··~ta~_istical Manual of 
Me,r,tal Disorders-Third Edition-Rev:i.se-ci'and have received a 
medical re-commendation for stimulant . ·_!Dedication as 
tre--atment. There will be - a _minimum of 20 subjects for 
each group. n,er,;.- is no di·fferentiation in terms ,-::,f 
se:, ; or et-hnic background. · S_ubjects will be drawn 
from the Psychopharmacology Clinic at Children's 
Mc-dical C~nter or from the School Preble-ms Clinic of 
the, University Affiliated CE-nter. 
V. Criteria for E:~clusion of Subjects: Pot&ntial subjects who 
are ,: urr ent l y ,::,r, othe.r medications or who have previous! y 
bc-,;,t1 ,:,n stimLllarit m,;.-dication will not be included. Also, 
potential subjt-•:ts ider,tified ......,o elect ~o. not participate--
in the study will not be included. Sutijects who develop 
r:,r,:,bl.,.r.-,ati,: side ef-f.,.cts will be re-mov<?d from the st:..idy. 
·r: .. So~ r ces of R~search Material~: Study data collected wi!l 
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be subject's performance on cognitiv~ measures, responses 
to affective measure-s; and · teac:h•r md par•nt behavioral 
checklists. Data obtaine-d wil'i be . use,d for research 
purposes as we-11 as providing data to parents conce-rning 
their _child's learning and behavioral problE-ms. 
VII. Recruitm.,,.nt of Subj•cts: -Subjects will be re-cruite,d from 
the Psychopharmacology Clinic of Children's'Medical Center 
and from the _; School ~robbms · Clinic - of. th.re Uni _versi ty 
Affiliated .C..ente-r · under tne direction of ·or. Mark Swanson. 
Explanation _ _ ·of .the- _re-sE.-arch project and informe-d cons.,,.nt 
wi 11 be obt,a1ned ·and .documented by use of attached informed 
consent ·, form . ·on- ·each potential. participant by the 
principal ihvestigato~. 
VIII. Potential Risks: 
Short-te-rm . side .. effects: \Most· common are-: appetite 
suppression, insomnl.a; · ··,irritability, w.ight loss, and 
occassionally, headac:h&s _and abdominal pain. . Toes..- are 
usually dose- re,lated:and. t _einpor~ry. - Nervous tics are also 
· seo?n occasionally · and -~,.usuafly . . stop when medication is 
discontinued~ .- :.: Rarely, . '·a.· s•rious · disorder cal 1 ed Tourette 
Syndrome .-c~n · 1:Je· ·,precipitated.::: · This· disorder involves 
irreversible/ • ·«i.uftipl; ·· fies '.and . ~omplusive vocalizations. 
·. • . . . • . .. 'IC"'_· •• • •• :, • • . 
If a - child taking '. st.imulant. medication develops tics, the-
physi~-~an will disc"ontinue- : m~ic:ation~ ·. 
Long-te'rm Side .:.Effects& .. :.:Pot~tial 'long ter~ side 
. e-ffe-cts • include, ·;,height -:.and'' .. weigh,t :., . ··suppre,ssion and 
cardiovascular e,ffec:ts- such a• ·J.ncr~••ed blood pre-9sure- and 
he-art rate-." . The risk" . ior .11: "of th.-se appears to be quite-
low. - · · Be-cause · improvements are often ,quite .. dramatic, there-
- -is a -P~tent,; ~1 .. - f~r · ~psychological ..• d~end.-nce-;·· · ·· ,EJnphasi s 
:should be ~made- ,that me-dicat .ion is an adjunct · to treatment 
an<L.aed.i.t..ing.J~:.bilJ;1~ri\iuor 5UCCH>S4tS to the ~ulant __ 
:medicat:Lon:; -~ould....;;.:;.1i~~;:~9 _t.if~~.:;: :::::Ev1.dt-n~)i: :_:-~;sucjges .~~ - ~that 
physical · .. depende-nce- -. or ; future · drug abuse because of the-
me-dicatioti is .;),e-ry "unlikely • . 
. ... .":'.... . . . ., ·-~ -. :. - " ·' 
IX. ·special .Pr~c:'eutic:,nsf See---abov• c:Usc~s .ion in pot~tial 
_ risks. · ~ - · · ·· - · ·:·· .... ,.,,.... 
X. Procedures to Maintain Confide-ntialityr- All information 
collected will be tre-ate-d "as c:onfide-ntial .information by 
those- involved in thE- . _t'e-search :-.study. _No information will 
be- ,:ommunicated . to ,:::,ttie-r·::i:ndividuals or age-ncie-s unless 
authorized by pare-l')tal pe-rmi"ss .ion. However, the- rese-arche-r 
is legally and e-thically r-equi 'r•d to .disclose confidential 
information if, a) thEere- is a clear emergency where there 
rnay be dange-r to th.,,. partfcipant or others, b) child abuse 
,:,r neglt"ct is suspected or re-ported, or c) the, re-se-archer 
is subpoenaed to surrende-r records and/or give- testimony. 
Records o f subjects will be maintained in locked file. 
F,:,t .:-,1': '- al P,::,tenti al bene-fits 
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participating ,:hild include t•sting that rnay provide in-
formation on the -child's learning o·r .behaivoral problems, 
m,:::ire accurate evaluation ·.·:·of ·whether the rnedic.ation is 
helping the ,:hil"d, increased . attention and concentration, 
higher sel f-este.,,rn, 1 ess .depression, reduced i mpul si veness, 
and less acting · ,:::iut behavior. '.·'' . f"inally, results of study 
may clarify the clinical picture and treatment of ADHD 
and UADD. . 
XII. Risk/Benefit Assessment: Given that .the· iow likelihood of 
developing serii::,us side effec.ts . from stimulant 111e-dication, 
the risks .are minimal. However, there is _the- _potential for 
significant benefit to the subject. Therefore, .it se.,,ms 
quite reasonable that · the subjects could participate 
without exp.,,riencing difficulty an _d 111ay provide positive 
experiences for . subjects - · who are · otherwise having 
adjustment difficulties at school and/or . horne. 
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You are beirq asked to participate in a research study. Persons who 
participate in researc:h are entitled to certain rights. 'Ihese rights 
include l::ut: are not limited to the subject's right to: 
1. Be inforne:l of the nature arx1 pn:pose of the research: 
2. Be given an explanation of the prccedures to be followed in the 
research, arx1 any drug or device to be utilized: 
3. Be given a description of any atterrlant cllscx:mforts an:i risks 
reasonable to be expected: 
4. Be given a disclosure of any benefits to the subject reasonable to be 
expected, if applicable: 
5. Be given a disclosure of any ~te alteniatives, drugs, or 
devices that might be advantageous to the subject, their relative 
risks an:i benefits: 
6. Be informed of the altei:natives of medical treaonent, if arrt, 
available to the subject durin; or after the experiment if 
canplications arise: 
7. Be given an opportunity to ask arq questions concerninq the 
research arxl. the procedures involved: 
8. Be instructed that consent to participate in the research may be 
withdrawn at any time, arxl. the subject may disccntinue 
participation without prejudice: 
9. Be given a CO'f1'i of the signed arxl. dated consent form: 
10. Ard be given the opportunity to decide to consent or not to 
cx:insent to participate in research without the intervention of any 
element of force, fraud, deceit, duress, coercion, or un:iue 
influence on the subject's decision. 
ur Southwestern lRB FOm ~4 
Revised 9/2/88 
Page 1 of _4 _ Pages 
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You have the right to privacy. All information that is obtained in 
connection with this study that c:an ba identified with yuu will remain 
cx:intidentia1 within the limits of state raw. Infcmnation gained fran this 
study that can be identified with you will be released only to the 
irnrestigators, an::i if afPLopdate, tc your i:hYSician an::i the sponsors of the 
study. For studies re;ul..ated by the Food an::i Dru;J .Adm:inistration (FDA) , 
there is a possibility that tha Fm nay inspect ycur records. 'Ihe results 
of this stLx:ly nay be plbl.ished in scientific joumals withc:x.xt .i.dentifyin;J 
you by nane. 
In addition, . t;he records of 'fOK participation in this study rnay be 
reviewed by members an::i staff of the Instituticnal ReView Boani, an::i you may 
be ccntact.ed by a representative of tha Board far info:rnation about your 
experience with . this study. u you wish, yuu may refuse to answer arr/ 
questions the Boan:i nay ask of you. wa also wail.d like for you to 
un:ierstan:i that your reo:,m nay be selected at l:8lXlClll (as by drawin;J straws) 
for examination by the Board to insure that this research. project is bein;J 
ccrducted prq,erly. 
We will n-ake every effort at preventinq ~ injury that could result 
fran this research. cartpensation for ~ injuries in:urrei as a result 
of participatin;J in the research is net available. 'Ihe investigators are 
prepared to advise you about medical treatment in case of adverse effects of 
these prt;,eedt.lres, 1o1ti.ch you shcw.d report to them prai¢.1y. 81cne numbers 
where the irnrestigators may be reached are listed in the headin; of this 
fonn. 
If you have any questions about the :cesearch ar about ycur rights as a 
subject, we want you to ask us. U you have questions later, ar if you 
wish to report a research-related injury (in addition to ootifyin;J the 
irnrestigator), you may call the <llaizman of the Institutional Review Board 
durin;J office hours at (214) 688-2258. 
Participation in this resean::h stD:iy is entirely voluntary. Refusal to 
participate will involve no penalty ar loss of benefits to which you are 
otherwise entitled. If you decide to participate, you are free to withdraw 
your con.sent an::i d.isoontinue participation at any time without affectin;J 
your status (as a patient, student, employee, etc.), or the medical care 
that you will receive. 
Any significant new f~ developed duri.rq the o::,.irse of the research 
which may relate to your will.in;ness to ccntinue participation in this study 
will be provided to you. 
YOO WI!L BE GIVEN A COPY OF 'IRIS <DNSENr FORM TO KEEP 
Pa e 2 
ur S<XJtlr,1estern rnB Form #4 (revised 9/88) 
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ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND UNDIFFERENTIATED 
ATTENTION-DEFICIT DISORDER: COGNITIVE AND AFFECTIVE DIFFERENCES 
AND THEIR RESPONSE TO STIMULANT MEDICATION 
PURPOSE: We are conducting a research study designed to help in 
the assessment of two types of attention-deficit disorders and to 
study stimulant medication effects for each type. The study will 
help us better understand the disorders and their treatment. 
WHAT YOU WILL BE ASKED TO DO IF YOU PARTICIPATE IN THIS STUDY: 
Each child included in the study has already had a diagnosis of 
Attent i on-deficit Hyperactivity Discrder(ADHD> or 
Undifferentiated Attention-deficit Disorder(UADD>, and the 
decision has been made to institute stimulant medication as part 
of the treatment program for your child. We are requesting your 
permission to use the data obtained during the evaluation and 
treatment of your child in order to obtain more information about 
children with Attention-deficit Disorder as a whole. Data 
includes scores from cognitive testing, child affective self-
report measures, and parent and teacher behavioral rating scales 
be f ore inst i tution of stimulant medication and 3 months later. 
EXPERIMENTAL PROCEDURES: As stated above, each child in the 
study has received a diagnosis of ADHD or UADD and the decision 
has been made to institute stimulant medication as part of the 
treatment program for your child. The medication used is 
methylphenidate hydrochloride or Ritalin which has been the 
traditional medication of first-choice for treatment of children 
wi th attentional pr o blems. Each child will receive a battery of 
cognitive and affective measures before treatment and later after 
the child has received the medication for 3 months. While the 
cost of the medication will be your responsibility, there will be 
no charge for the testing conducted. 
POSSIBLE RIS KS AND DISCOMFORTS: The risks of participating in 
this stud y a re minimal. Participation is strictly voluntary, and 
you or y our child may withdraw at any time witho u t affecting your 
ch i ld 's treatment program. Most common short-term side effects 
from Rital i n are: appetite suppression, insomnia, irritability, 
weight loss, and occasionally headaches and abdominal pain. 
These are usually dose related and temporary. Nervous tics are 
also seen occasionally and usually stop when medication is 
discontinued . Rarely, a serious disorder called Tourette 
Syndrome can be precipitated. This disorder involves 
i rreversible, multiple tics and compulsive vocalizations. If a 
child taking stimulant medication develops tics, the medication 
wi il be discontinued and his/her physician should be contacted. 
Al s o, this medication can produce signs of psychosis at high 
doses. Potential long-term side effects are: height and weight 
su p p r ession and cardiovascular effects such as increased blood 
pressure and heart rate. The risk for all of these appears to be 
quite low. Concern is often raised about potential physical 
depen d ence or future drug abuse. Evidence suggests that this is 
ver y unli kel y . Because improvements are often quite dramatic, 
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there is a potential for psychological dependence. Emphasis 
should be made that medication is an adjunct to treatment and 
crediting a child's major successes to the stimulant medication 
should be avoided. 
POSSIBLE BENEFITS: Potential benefits for you and your child 
include testing that may provide information on your child 's 
:earning or behavioral problems, more accurate evaluation of 
whether the medication is helping the child, increased attention 
and concentration, higher self-esteem, less depression, reduced 
impulsiveness, and less acting out behavior. Finally, results cf 
the studv mav clarify the clinical picture and treatment of 
attention-deficit disorders. 
ALTERNATIVES TO PARTICIPATION: There are other 
treatment 
possibilities to attention-deficit disorders. In 
terms of 
,neoi cati ans, sometimes Cylert or De>:edrine is 
used in the 
There are also 
treatment of attention-deficit disorders. psychosocial aporoaches such as behavior modification techniques, 
cognitive training, and parent training. Ideally, a combination 
of approaches is desired. 
YOU ARE MAl<ING A DECISION WHETHER OR NOT TO PARTICIPATE IN THIS 
STUDY. YOU SHOULD NOT SIGN UNTIL YOU UNDERSTAND ALL THE 
I :'JFORMA, I :N PF:ESENTED IN THE PREV I OLIS PAGES AND UNTIL ALL YC:UR 
QUES,iONS ABOUT THE RESEARCH HAVE BEEN ANSWERED TO YOUR 
SATISFACTION. YOUR SIGNATURE INDICATES THAT YOU HAVE DEC:DED ~8 
F'ARTICIPA,E HAVING READ <OR BEEN READ) THE INFORMATION PROVID!:::D 
ABD'-JE. 
Name o-f S L1D i2c-:: Age 
Sig natur e of Legally Hesponsible Date 
1-:,:epre=:eni:a'Ci \.:e 
Re1acionsn1p to Subject 
3i~natur~ o f ~itness / investigator 
Ple ase prov1oe the following information so that you may be 
=anc3c~eo if there are significant new findings are developed 
during the course of the research which may affect y our 
w1liingne5S ~o p art i cicate i n the study. 
~·l,::,m<~: 
()c .1Ci:- r·::'::: ·:;; ·:1.nci r:·hon r.? i'-Jumaer: ------------------------
- --- ·----- --- --------------------------------
Appendix D 
Children's Depression Inventory 
CD INYENTORY 
NAME: 
---------~-
DATE: 
-------
I I I I I I I CASENO.: l_l_l I __ _ I 
111 
INVENTORY NO.: Ll_l 
r1rr1r1 
FORM NO.: __ .LJ_I 
KIDS SOMETIMES HAVE. DIFFERENT FEELINGS AND IDEAS, 
THIS FORM LISTS THE FEELINGS AND IDEAS IN GROUPS, FROM EAOf GROUP, PICK~ 
SENTENCE THAT DESCRIBES YOU BEST FOR THE PAST TWO WEEKS. AFTER YOU PICK A 
SENTENCE FROM THE FIRST GROUP, GO ON TO THE NEXT GROUP. 
THERE IS NO RIGHT ANSWER OR WRONG ANSWER, JUST PICK nfE SENTENCE THAT BEST 
DESCRIBES THE WAY YOU HAVE BEEN RECENTLY. PUT A HAAK LIKE THIS -X- NEXT TO 
YOUR ANSWER, PUT THE MARK IN THE BOX NEXT TO THE SENTENCE THAT YOU PICK. 
HERE IS AN EXAMPLE OF HOW THIS FORM WORKS. TRY IT. PUT A HARK NEXT TO THE 
~ 
SENTENCE THAT DESCRIBES YOU BEST. 
EXAMPLE: 
l=I I READ BOOKS ALL THE TIME 
1:::::1 I READ BOOKS ONCE IN A WHILE (:::::1 I NEVER READ BOOKS 
Developea by M. Kovacs, Ph.D. On1vers1ty of Pittsburgh School of Med1c1ne, 
Department of Psychiatry, Pittsburgh, PA 15261. Hot to be used, quoted, 
or reproduced without permission. Rev. 3/75; 2/76; 5/77; 7/77 
Format Change, 8/79 
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Copyright 1979. M. Kovacs, Ph.D. Universitr of Pitts-
burg School of Medicine, Departmen~ of Psy~h1~try, . 
Pittsburg, PA 15261. Reprinted with permission of Maria 
Kovacs, Ph.D .. 
/ REMEMBER, PICK OUT THE SENTENCES THAT DESCRIBE YOUR FEELINGS AND IDEAS IN 
THE PAST TWO WEEKS. 
1. 1==1 
1==1 
1==1 
2. 1==1 
1==1 
1==1 
3. 1.==1 
1==1 
1==1 
4. 1.==1 
1.==1 
1==1 
5. 1:=1 
1:=1 
1==1 
6. 1:=1 
1==1 
1==1 
7. 1==1 
1==1 
1==1 
I AM SAD ONCE IN A WHILE 
I AM SAD MANY TIMES 
I AM SAD ALL THE TIME 
NOTHING WILL EVER WORK OUT FOR ME 
I AM NOT SURE IF THINGS WILL WORK OUT FOR ME 
THINGS.WILL WORK OUT FOR ME O.K. 
DO MOST HINGS O.K. 
DO MANY THINGS WRONG 
DO EVERYTHING WRONG 
HAVE FUN IN MANY THINGS 
I HAVE FUN IN SOME THINGS 
NOTHING IS FUN AT ALL 
I AM BAD ALL THE TIME 
I AH BAD MANY TIMES 
I AM BAD ONCE IN A WHILE 
I THINK ABOUT BAD THINGS HAPPENING TO ME ONCE IN A WHILE 
I WORRY THAT BAD THINGS WILL HAPPEN TO ME 
I AM SURE THAT ERRIBLE THINGS WILL HAPPEN TO HE 
HATE MYSELF 
DO NOT LIKE MYSELF 
LIKE MYSELF 
5 
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8. 1==1 ALL BAD THINGS ARE MY FAULT 
1==1 MANY BAD THINGS ARE MY FAULT 
1==1 BAD TH~GS ARE NOT USUALLY MY FAULT 
9. 1==1 I DO NOT THINK ABOUT KILLING MYSELF 
1==1 I THINK ABOUT KILLING MYSELF BUT I WOULD NOT DO IT 
1==1 · I WANT TO KILL MYSELF 
10. 1==1 FEEL LIKE CRYING EVERYDAY 
1==1 FEEL LIKE CRYING MANY DAYS 
1==1 I FEEL LIKE CRYING ONCE IN A WHILE 
11. 1==1 THINGS BOTHER ME ALL THE TIME 
1==1 THINGS BOTHER ME MANY TIMES 
1==1 THINGS BOTHER ME ONCE IN A WHILE 
12. 1==1 LIKE BEING WITH PEOPLE 
1==1 DO NOT LIKE BEING WITH PEOPLE MANY TIMES 
1==1 I 00 NOT WANT TO BE WITH PEOPLE AT ALL 
13. ,==1 I CANNOT MAKE UP MY MINO ABOUT THINGS 
1==1 IT IS HARD TO MAKE UP MY MIND ABOUT THINGS 
1==1 MAKE UP MY MIND ABOUT THINGS EASILY 
14. 1==1 LOOK O.K. 
1::=1 THERE ARE SOME BAD THINGS ABOUT MY LOOKS 
1==1 LOOK UGLY 
15. --, ,_ HAVE TO PUSH MYSELF ALL THE TIME TO DO HY SCHOOLWORK 
1==1 HAVE TO PUSH MYSELF MANY TIMES TO DO MY SCHOOLWORK 
,==, DOING SCHOOLWORK IS NOT A BIG PROBLEM 
6 
REMEMBER, DESCRIBE HOW YOU HAVE BEEN IH THE PAST TWO WEEKS. 
16. 1=:1 I HAVE TROUBLE SLEEPING EVERY NIGHT 
1==1 I HAVE TROUBLE SLEEPING MANY NIGHTS 
' 1==1 I SLEEP PRETTY WELL 
17. 1==1 I AM TIRED ONCE IN A WHILE 
1=:1 I AM TIRED MANY DAYS 
1==1 I AM TIRED All THE TIME 
18. 1=:1y MOST DAYS I DO NOT FEEL LIKE EATING 
1==1 MANY DAYS I DO NOT FEEL LIKE EATING 
1=:1 I EAT PRETTY WELL 
19. 1==1 I DO NOT WORRY ABOUT ACHES AND PAINS 
1==1 I WORRY ABOUT ACHES ANO PAINS MANY TIMES 
l==ly I WORRY ABOUT ACHES ANO PAINS ALL THE TIME 
20. 1==1 I DO NOT FEEL ALONE 
1==1 I FEEL ALONE MANY TIMES 
' 1==1 I FEEL ALONE ALL THE TIME 
21. 1==1 I NEVER HAVE FUN AT SCHOOL 
1==1 I HAVE FUN AT SCHOOL ONLY ONCE IN A WHILE 
1==1 I HAVE FUN AT SCHOOL MANY TIMES 
22. 1.:=1 I HAVE PLENTY OF FRIENDS 
1==1 I HAVE SOME FRIENDS BUT I WISH I HAD MORE 
1==1 I DO NOT HAVE ANY FRIENDS 
i:33 
23. 1::=1 HY SCHOOL WORK IS ALRIGHT 
,=:i MY SCHOOL WORK IS NOT AS GOOD AS BEFORE 
' 
,=:=i I DO VERY BADLY IN SUBJECTS I USED TO BE GOOD IN 
24. 1==1 I CAN NEVER BE AS GOOD AS OTHER KIDS 
1==1 I CAN BE AS GOOD AS omER KIDS IF I WANT TO 
1--i I AM JUST AS GOOD AS omER KIDS 
25. 1==1 NOBODY REALLY LOVES ME 
1==1 I AM NOT SURE IF ANYBODY LOVES ME 
1=:1 I AM SURE THAT SOMEBODY LOVES ME 
26. 1==1 I USUALLY DO WHAT I AM TOLD 
1==1 I DO NOT DO WHAT I AM TOLD MOST IMES 
,==1 I NEVER DO WHAT I AM TOLD 
27. 1==1 I GET ALONG WITH PEOPLE 
1==1 I GET INTO FIGHTS MANY TIMES 
' 
1==1 I GET INTO FIGHTS ALL THE TIME 
TifE END 
TliAHK YOU FOR FILLIK6 OUT THIS FORM 
SU!:. _____ _ 
ADMINISTRAT!ON: O. INDIVIDUAL ___ _ 
I. GROUP 
------
8 
{i) University of Pittsburgh 
WESTERN PSYCHIATRIC INSTITUTE: ANO CUNIC 
or. Richard campbell 
5801 Spring Valley l409W 
Dallas, TX 75240 
Dear Or. campbell: 
August 29, 1989 
Thank you !er your recent letter in which you requested infor-
mation regarding the Olildren•s Oepressicn Inventory (CDIJ. 
As per your request, enclosed is an article in whic.'l the CDI, 
its development, and psyc.~cmetric prcpertie• ara described. 
Also, enclosed are tvo c::ipies at the CDI, inst-..-ucticns !er its 
administr3ticn, a sc~ring templata, and a ra!erenca list. Please 
note that the CDI is c::ipyrighted. This letter gives you 
per::issicn ta reproduce it only !er your purposes, •• 51:ated in 
your lett2r. In the c::tse that other pr=tessionals ara intarested 
in obtaining t.~e inst:..-ument, please aak them to vrita to 111e 
dire~.ly. 
! vculd appr~ciat2 your lcaeping me pcstad on the progress o! 
your vcrx l)y !or..rarding any ;,er:i:1ent nprint3 or :aanusc:::'ipt:s. I 
hope t.~at you'll t!nd t.~e above in!cr=aticn use!ul. If you bava 
any questions, please !eel trae to get in touch vith .. again. 
Finally, in order tc cover the ccats ct the enclosed material, 
lcindl y tcr..rard a c.'lec.!t or lllOney order !er the amcunt ot $,. 75 
(tvo dollars and seventy-five cant.sl payable t=: C1ildhocd 
Depression Resean:..~ Program, WPIC: plea•• ••nd the c:beck to ay 
attan1:ion. 
MlC/bb 
Enc.lcsures: CDI {2) ,· instructions !or adJllinist--ation. •~ring 
tamplata, Psychopbanula>lcgy BUllatin Article, CDI 
n:farencas 
JSI 1 o·HARA STREtT. PJTTSBURCH. PA 1'213-z,qJ 
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Appendix E 
Conners Parent Rating Scale-Revised 
PARENT'S QIESTior.tAIRE 
Name or Child·---------------------- Date _______ _ 
Please answer all questions. ·aeside each ite11 below./: 
indicate the degree or the problem by a check mark ( ) Not at Just a Pretty very 
all little much much 
l. Picks at thinos (nails, rtnoers, hair, clothina). 
2. Sassy to qrown-uos. 
3. Problems with making or keepino friends. I 
4. Excitable , imoulsive. 
5. rants to run things. 
6. sucks or chews (thumb: cloth inc· blankets). 
7. Cries easily or often. 
8. carr i es a chic on his shoulder. 
9. Daydreams. I 
10. DHriculty in l earnino. I 
11. Res tle ss in th e "sou i rmv• sense. I I I 
12. ,earful or new situations; 
aoino to school). new people or places; I 
13. Restless. always uo and on the ao. 
14. Destructive. I 
15 , Tells lies or stories that aren•t true. I 
16. Shy. I 
17. Gets i nt o more t rouble than others saae aae. 
18. speaks differently from others saae age (baby talk; 
stutterino· hard to understand). 
19 . Denies mistakes or blames others . 
20. Quarr elsome . I I 
21. Pouts and sulks . 
22. Stea l s . I I 
23. Disobedien t or obeys but resentfully. I 
24. wor ries more t han others (about being alone; 
illness or death). 
25. Fails to finish thinos. 
26. F"eelinos easily hurt. 
27. Bullies others. 
28 . unable to stoo a reoetitive activity. I 
29 . cr uel . 
30. Childish or immature (wants help he shouldn't need; 
clinos: needs constant reassurance). 
Not at Just a Pretty Very 
all little much much 
:n. 01stractibil1tv or attention scan a problem. 
32. Headaches. 
33. Mood chanoes quicklv and drastically. 
34. Ooesn•t like or doesn•t t'ollow rules or I restrictions. 
I 35. ,1ohts constantly. I 
36. Ooesn • t oet alona well with brothers or sisters. I 
37. Easily frustrated in efforts. I I 
38. Disturbs other children. I I 
39 . Basically an unhacpy child. I 
40. Problems with eating (poor appetite; up between I bites). 
41. Stomach aches. I I 
42 . Problems with sleep (can•t · f'all aaleep; up too I I eerlv· up in the niqht). 
43 . Other aches and oains. I 
44 . Vomitina or nausea. I I 
45. , eels cheated in f'amilv circle. I 
46. Boasts and braqs. 
47. Lets self be pushed around. 
48. Bowel problems 
cons ti cation ) . (frequently loose; irregular habits; 
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Appendix F 
Conner's Teacher Rating Scale 
T£ACHER'S QUESTIOMMIRE 
Name of Child·---------------------- Grade _______ _ 
Date of Evaluation ______________ _ 
Please answer all questions. Beside each t;,em, indicate 
the degree of the problem by a check mark Not at Just a Pretty very 
all little IIUCh much 
l. Restless in the •squirmv• sense. 
2. Makes inaopropriate noises when he shouldn't. 
:,. Demands must be met !mediately. 
4. Acts •smart• (imoudent or sassv). 
,. Temoer outbursts and unoredictable behavior. 
6. overlv sensitive to criticism. 
7. Distractibilitv or attention soan a orobles. 
a. Disturbs other children. 
9. Daydreams. 
10. Pouts and sulks. 
11. Mood chances auicklv and drastically. I 
12. Quarrelsome. I 
lJ. Submissive attitude toward authority. 
u. Restless . alwavs •uo and on the oo.• I 
l!S. Excitable, imoulsive. 
16. Excessive demands ror teacher•s attention. 
17. Aooears to be unaccented bv orouo. 
18. Aooears to be easilv led bv other children. I I 
19, No sense of rair olay . 
20. Aooears to lack leadershio. I 
21. F'ails to rtnish thin as that he starts. I 
22. Childish and immature. 
2:,. Denies mistakes or blames others. 
24. Does not aet alone well with other children. 
2!S. uncooperative with classmates. 
26, Easilv rrustrated in efforts. 
27, uncoooerati ve with teacher. 
28. 01 rr1cu1tv in learnina. 
VITA 
Richard Alan Campbell 
Candidate for the Degree of 
Doctor of Philosophy 
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